{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T00:45:21Z","timestamp":1794271521232,"version":"4.9.0"},"reference-count":345,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100024586","name":"Human Resource Development Centre, Council of Scientific And Industrial Research","doi-asserted-by":"publisher","award":["09\/086(1495)\/2021-EMR-I"],"award-info":[{"award-number":["09\/086(1495)\/2021-EMR-I"]}],"id":[{"id":"10.13039\/501100024586","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001412","name":"Council of Scientific & Industrial Research","doi-asserted-by":"publisher","award":["35111359"],"award-info":[{"award-number":["35111359"]}],"id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011207","name":"New York Academy of Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011207","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001407","name":"India Ministry of Science & Technology Department of Biotechnology","doi-asserted-by":"publisher","award":["DBT\/2021-426 22\/IIT-D\/1556"],"award-info":[{"award-number":["DBT\/2021-426 22\/IIT-D\/1556"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009481","name":"Tata Group","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009481","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advanced Drug Delivery Reviews"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.addr.2026.115812","type":"journal-article","created":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T07:15:53Z","timestamp":1771226153000},"page":"115812","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Challenges and developments in the manufacturing of high-concentration biotherapeutic monoclonal antibodies"],"prefix":"10.1016","volume":"232","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3395-6661","authenticated-orcid":false,"given":"Anurag S.","family":"Rathore","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subhankar","family":"Metya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rashmi","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitika","family":"Nitika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.addr.2026.115812_bb0005","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1093\/jaoacint\/qsad094","article-title":"Stability and Biosimilarity Assessment of Bevacizumab Monoclonal Antibody; Orthogonal Testing Protocol Coupled With Peptide Mapping\u2013Principal Component Analysis","volume":"107","author":"Abdelghaffar","year":"2024","journal-title":"Journal of AOAC International"},{"issue":"2","key":"10.1016\/j.addr.2026.115812_bb0010","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.xphs.2023.11.017","article-title":"Filling Unit Operation for Biological Drug Products: Challenges and Considerations","volume":"113","author":"Adler","year":"2024","journal-title":"Journal of Pharmaceutical Sciences"},{"key":"10.1016\/j.addr.2026.115812_bb0015","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.memsci.2019.02.040","article-title":"Modelling ultrafiltration performance by integrating local (critical) fluxes along the membrane length","volume":"578","author":"Aguirre-Montesdeoca","year":"2019","journal-title":"Journal of Membrane Science"},{"key":"10.1016\/j.addr.2026.115812_bb0020","series-title":"Sterile Drug Products: Formulation, Packaging, Manufacturing and Quality","author":"Akers","year":"2016"},{"issue":"6","key":"10.1016\/j.addr.2026.115812_bb0025","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.1021\/acs.chemrev.3c00615","article-title":"Molecular Crowding: The History and Development of a Scientific Paradigm","volume":"124","author":"Alfano","year":"2024","journal-title":"Chemical Reviews"},{"issue":"2","key":"10.1016\/j.addr.2026.115812_bb0030","doi-asserted-by":"crossref","first-page":"291","DOI":"10.3390\/ph16020291","article-title":"Analytical Techniques for the Characterization and Quantification of Monoclonal Antibodies","volume":"16","author":"Alhazmi","year":"2023","journal-title":"Pharmaceuticals"},{"issue":"10","key":"10.1016\/j.addr.2026.115812_bb0035","doi-asserted-by":"crossref","first-page":"3319","DOI":"10.1002\/jps.24561","article-title":"Sterile Filtration of Highly Concentrated Protein Formulations: Impact of Protein Concentration, Formulation Composition, and Filter Material","volume":"104","author":"Allmendinger","year":"2015","journal-title":"Journal of Pharmaceutical Sciences"},{"issue":"9","key":"10.1016\/j.addr.2026.115812_bb0040","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.3390\/w13091327","article-title":"A Comprehensive Review on Membrane Fouling: Mathematical Modelling, Prediction, Diagnosis, and Mitigation","volume":"13","author":"AlSawaftah","year":"2021","journal-title":"Water"},{"issue":"2","key":"10.1016\/j.addr.2026.115812_bb0045","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1002\/bit.27598","article-title":"Designing scalable ultrafiltration\/diafiltration process of monoclonal antibodies via mathematical modeling by coupling mass balances and Poisson\u2013Boltzmann equation","volume":"118","author":"Ambro\u017ei\u010d","year":"2021","journal-title":"Biotechnology and Bioengineering"},{"issue":"5","key":"10.1016\/j.addr.2026.115812_bb0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0232713","article-title":"Modeling and mitigation of high-concentration antibody viscosity through structure-based computer-aided protein design","volume":"15","author":"Apgar","year":"2020","journal-title":"PLOS ONE"},{"key":"10.1016\/j.addr.2026.115812_bb0055","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1016\/j.csbj.2024.05.041","article-title":"A framework for the biophysical screening of antibody mutations targeting solvent-accessible hydrophobic and electrostatic patches for enhanced viscosity profiles","volume":"23","author":"Armstrong","year":"2024","journal-title":"Computational and Structural Biotechnology Journal"},{"key":"10.1016\/j.addr.2026.115812_bb0060","doi-asserted-by":"crossref","DOI":"10.1101\/2024.03.07.583917","article-title":"Enhancing viscosity control in antibody formulations: A framework for the biophysical screening of mutations targeting solvent-accessible hydrophobic and electrostatic patches","author":"Armstrong","year":"2024","journal-title":"Bioengineering"},{"key":"10.1016\/j.addr.2026.115812_bb0065","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2147\/DDDT.S287323","article-title":"Subcutaneous Delivery of High-Dose\/Volume Biologics: Current Status and Prospect for Future Advancements","volume":"15","author":"Badkar","year":"2021","journal-title":"Drug Design, Development and Therapy"},{"issue":"6","key":"10.1016\/j.addr.2026.115812_bb0070","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1002\/btpr.2544","article-title":"pH variations during diafiltration due to buffer nonidealities","volume":"33","author":"Baek","year":"2017","journal-title":"Biotechnology Progress"},{"issue":"4","key":"10.1016\/j.addr.2026.115812_bb0075","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1002\/biot.201400531","article-title":"Buffer-free therapeutic antibody preparations provide a viable alternative to conventionally buffered solutions: From protein buffer capacity prediction to bioprocess applications","volume":"10","author":"Bahrenburg","year":"2015","journal-title":"Biotechnology Journal"},{"issue":"9","key":"10.1016\/j.addr.2026.115812_bb0080","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1016\/j.xphs.2020.05.015","article-title":"Impact of mAb Aggregation on Its Biological Activity: Rituximab as a Case Study","volume":"109","author":"Bansal","year":"2020","journal-title":"Journal of Pharmaceutical Sciences"},{"issue":"11","key":"10.1016\/j.addr.2026.115812_bb0085","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/s11095-019-2690-8","article-title":"Analytical Platform for Monitoring Aggregation of Monoclonal Antibody Therapeutics","volume":"36","author":"Bansal","year":"2019","journal-title":"Pharmaceutical Research"},{"issue":"6","key":"10.1016\/j.addr.2026.115812_bb0090","doi-asserted-by":"crossref","first-page":"908","DOI":"10.3390\/ph18060908","article-title":"Innovative Formulation Strategies for Biosimilars: Trends Focused on Buffer-Free Systems, Safety, Regulatory Alignment, and Intellectual Property Challenges","volume":"18","author":"Bas","year":"2025","journal-title":"Pharmaceuticals"},{"issue":"5","key":"10.1016\/j.addr.2026.115812_bb0095","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1002\/btpr.2366","article-title":"Glycosylation of monoclonal antibody products: Current status and future prospects","volume":"32","author":"Batra","year":"2016","journal-title":"Biotechnology Progress"},{"issue":"10","key":"10.1016\/j.addr.2026.115812_bb0100","doi-asserted-by":"crossref","first-page":"4158","DOI":"10.1002\/jps.22597","article-title":"Effects of Surfaces and Leachables on the Stability of Biopharmaceuticals","volume":"100","author":"Bee","year":"2011","journal-title":"Journal of Pharmaceutical Sciences"},{"issue":"2","key":"10.1016\/j.addr.2026.115812_bb0105","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s11367-011-0248-z","article-title":"A life cycle assessment of injectable drug primary packaging: Comparing the traditional process in glass vials with the closed vial technology (polymer vials)","volume":"16","author":"Belboom","year":"2011","journal-title":"The International Journal of Life Cycle Assessment"},{"key":"10.1016\/j.addr.2026.115812_bb0110","first-page":"473","article-title":"Evaluation of the impact of viscosity, injection volume, and injection flow rate on subcutaneous injection tolerance","volume":"8","author":"Berteau","year":"2015","journal-title":"Medical Devices: Evidence and Research"},{"issue":"4","key":"10.1016\/j.addr.2026.115812_bb0115","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3390\/antib12040078","article-title":"Prediction of Antibody Viscosity from Dilute Solution Measurements","volume":"12","author":"Bhandari","year":"2023","journal-title":"Antibodies"},{"issue":"11","key":"10.1016\/j.addr.2026.115812_bb0120","doi-asserted-by":"crossref","first-page":"3330","DOI":"10.1016\/j.xphs.2020.08.013","article-title":"High Performance Size Exclusion Chromatography and High-Throughput Dynamic Light Scattering as Orthogonal Methods to Screen for Aggregation and Stability of Monoclonal Antibody Drug Products","volume":"109","author":"Bhirde","year":"2020","journal-title":"Journal of Pharmaceutical Sciences"},{"issue":"3","key":"10.1016\/j.addr.2026.115812_bb0125","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/btpr.2252","article-title":"Ultrafiltration of highly concentrated antibody solutions: Experiments and modeling for the effects of module and buffer conditions","volume":"32","author":"Binabaji","year":"2016","journal-title":"Biotechnology Progress"},{"issue":"5","key":"10.1016\/j.addr.2026.115812_bb0130","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s40259-018-0295-0","article-title":"Subcutaneous Administration of Biotherapeutics: An Overview of Current Challenges and Opportunities","volume":"32","author":"Bittner","year":"2018","journal-title":"BioDrugs"},{"issue":"1","key":"10.1016\/j.addr.2026.115812_bb0135","doi-asserted-by":"crossref","first-page":"2044744","DOI":"10.1080\/19420862.2022.2044744","article-title":"Computational models for studying physical instabilities in high concentration biotherapeutic formulations","volume":"14","author":"Blanco","year":"2022","journal-title":"mAbs"},{"issue":"22","key":"10.1016\/j.addr.2026.115812_bb0140","doi-asserted-by":"crossref","first-page":"5817","DOI":"10.1021\/jp412301h","article-title":"Protein\u2013Protein Interactions in Dilute to Concentrated Solutions: \u03b1-Chymotrypsinogen in Acidic Conditions","volume":"118","author":"Blanco","year":"2014","journal-title":"The Journal of Physical Chemistry. B"},{"issue":"10","key":"10.1016\/j.addr.2026.115812_bb0145","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3390\/membranes10100284","article-title":"Forward Osmosis as Concentration Process: Review of Opportunities and Challenges","volume":"10","author":"Blandin","year":"2020","journal-title":"Membranes"},{"key":"10.1016\/j.addr.2026.115812_bb0150","article-title":"The effect of mAb and excipient cryoconcentration on long-term frozen storage stability \u2013 Part 1: Higher molecular weight species and subvisible particle formation","volume":"4","author":"Bluemel","year":"2022","journal-title":"International Journal of Pharmaceutics: X"},{"issue":"1","key":"10.1016\/j.addr.2026.115812_bb0155","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/btpr.523","article-title":"Effect of protein and solution properties on the donnan effect during the ultrafiltration of proteins","volume":"27","author":"Bolton","year":"2011","journal-title":"Biotechnology Progress"},{"issue":"2","key":"10.1016\/j.addr.2026.115812_bb0160","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jconrel.2006.05.027","article-title":"A recombinant human enzyme for enhanced interstitial transport of therapeutics","volume":"114","author":"Bookbinder","year":"2006","journal-title":"Journal of Controlled Release"},{"issue":"4","key":"10.1016\/j.addr.2026.115812_bb0165","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/(SICI)1097-0290(19980820)59:4<451::AID-BIT8>3.0.CO;2-F","article-title":"Analysis of protein fouling during ultrafiltration using a two-layer membrane model","volume":"59","author":"Boyd","year":"1998","journal-title":"Biotechnology and Bioengineering"},{"issue":"1","key":"10.1016\/j.addr.2026.115812_bb0170","doi-asserted-by":"crossref","first-page":"1940666","DOI":"10.1080\/19420862.2021.1940666","article-title":"Stability of a high-concentration monoclonal antibody solution produced by liquid\u2013liquid phase separation","volume":"13","author":"Bramham","year":"2021","journal-title":"mAbs"},{"issue":"5","key":"10.1016\/j.addr.2026.115812_bb0175","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.jpba.2005.02.037","article-title":"Guidelines from the International Conference on Harmonisation (ICH)","volume":"38","author":"Branch","year":"2005","journal-title":"Journal of Pharmaceutical and Biomedical Analysis"},{"issue":"9205","key":"10.1016\/j.addr.2026.115812_bb0180","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0140-6736(00)01034-5","article-title":"Therapeutic monoclonal antibodies","volume":"355","author":"Breedveld","year":"2000","journal-title":"The Lancet"},{"key":"10.1016\/j.addr.2026.115812_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.memsci.2022.120333","article-title":"Modeling the Gibbs\u2013Donnan effect during ultrafiltration and diafiltration processes using the Poisson\u2013Boltzmann theory in combination with a basic Stern model","volume":"648","author":"Briskot","year":"2022","journal-title":"Journal of Membrane Science"},{"issue":"1","key":"10.1016\/j.addr.2026.115812_bb0190","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1205\/026387697523381","article-title":"Mixing With Helical Ribbon Impellers: Effect of Highly Shear Thinning Behaviour and Impeller Geometry","volume":"75","author":"Brito-De La Fuente","year":"1997","journal-title":"Chemical Engineering Research and Design"},{"key":"10.1016\/j.addr.2026.115812_bb0195","series-title":"Pharmaceutical Preformulation and Formulation","article-title":"Parenteral Dosage Forms","author":"Broadhead","year":"2009"},{"issue":"6","key":"10.1016\/j.addr.2026.115812_bb0200","doi-asserted-by":"crossref","first-page":"469","DOI":"10.3390\/gels9060469","article-title":"Rheological Considerations of Pharmaceutical Formulations: Focus on Viscoelasticity","volume":"9","author":"Budai","year":"2023","journal-title":"Gels"},{"issue":"3","key":"10.1016\/j.addr.2026.115812_bb0205","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1021\/acs.jmedchem.1c02010","article-title":"Aggregation Time Machine: A Platform for the Prediction and Optimization of Long-Term Antibody Stability Using Short-Term Kinetic Analysis","volume":"65","author":"Bunc","year":"2022","journal-title":"Journal of Medicinal Chemistry"},{"issue":"5","key":"10.1016\/j.addr.2026.115812_bb0210","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1007\/s10529-013-1445-6","article-title":"Biopharmaceutical liquid formulation: A review of the science of protein stability and solubility in aqueous environments","volume":"36","author":"Bye","year":"2014","journal-title":"Biotechnology Letters"},{"issue":"3","key":"10.1016\/j.addr.2026.115812_bb0215","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1002\/jps.23861","article-title":"Control of Protein Particle Formation During Ultrafiltration\/Diafiltration Through Interfacial Protection","volume":"103","author":"Callahan","year":"2014","journal-title":"Journal of Pharmaceutical Sciences"},{"issue":"4","key":"10.1016\/j.addr.2026.115812_bb0220","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1002\/jps.21530","article-title":"Overlooking Subvisible Particles in Therapeutic Protein Products: Gaps That May Compromise Product Quality","volume":"98","author":"Carpenter","year":"2009","journal-title":"Journal of Pharmaceutical Sciences"},{"issue":"1","key":"10.1016\/j.addr.2026.115812_bb0225","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.memsci.2011.09.004","article-title":"Protein concentration with single-pass tangential flow filtration (SPTFF)","volume":"384","author":"Casey","year":"2011","journal-title":"Journal of Membrane Science"},{"issue":"6","key":"10.1016\/j.addr.2026.115812_bb0230","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.535","article-title":"The pharmacology and therapeutic applications of monoclonal antibodies","volume":"7","author":"Castelli","year":"2019","journal-title":"Pharmacology Research & Perspectives"},{"issue":"6","key":"10.1016\/j.addr.2026.115812_bb0235","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1080\/07388551.2021.1947182","article-title":"Current evidence in high throughput ultrafiltration toward the purification of monoclonal antibodies (mAbs) and biotechnological protein-type molecules","volume":"42","author":"Castro-Mu\u00f1oz","year":"2022","journal-title":"Critical Reviews in Biotechnology"},{"key":"10.1016\/j.addr.2026.115812_bb0240","article-title":"Advances in Digitalization and Automation of Aseptic Processing. BioPharm International","author":"Challener","year":"2026","journal-title":"BioPharm International."},{"issue":"12","key":"10.1016\/j.addr.2026.115812_bb0245","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1021\/js960080y","article-title":"Surface-induced denaturation of proteins during freezing and its inhibition by surfactants","volume":"85","author":"Chang","year":"1996","journal-title":"Journal of Pharmaceutical Sciences"},{"issue":"10","key":"10.1016\/j.addr.2026.115812_bb0250","doi-asserted-by":"crossref","DOI":"10.1002\/biot.202400212","article-title":"Explainable Machine Learning Models to Predict Gibbs\u2013Donnan Effect During Ultrafiltration and Diafiltration of High-Concentration Monoclonal Antibody Formulations","volume":"19","author":"Chen","year":"2024","journal-title":"Biotechnology Journal"},{"issue":"6","key":"10.1016\/j.addr.2026.115812_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.xphs.2024.10.020","article-title":"Impact of surface tension, viscosity, pump settings, and nozzle size on filling process capability and accuracy in high-concentration biopharmaceuticals","volume":"114","author":"Chen","year":"2025","journal-title":"Journal of Pharmaceutical Sciences"},{"issue":"12","key":"10.1016\/j.addr.2026.115812_bb0260","doi-asserted-by":"crossref","first-page":"4291","DOI":"10.1002\/jps.23748","article-title":"Linking the Solution Viscosity of an IgG2 Monoclonal Antibody to Its Structure as a Function of pH and Temperature","volume":"102","author":"Cheng","year":"2013","journal-title":"Journal of Pharmaceutical Sciences"},{"key":"10.1016\/j.addr.2026.115812_bb0265","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2025.1644318","article-title":"Isolator-based point-of-care manufacturing: A practical solution for GMP-compliant cell and extracellular vesicles therapy production","volume":"13","author":"Chiu","year":"2025","journal-title":"Frontiers in Bioengineering and Biotechnology"},{"issue":"3","key":"10.1016\/j.addr.2026.115812_bb0270","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1021\/acs.molpharmaceut.5b00817","article-title":"Therapeutic Antibody Engineering To Improve Viscosity and Phase Separation Guided by Crystal Structure","volume":"13","author":"Chow","year":"2016","journal-title":"Molecular Pharmaceutics"},{"issue":"6","key":"10.1016\/j.addr.2026.115812_bb0275","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.1021\/acs.molpharmaceut.3c00023","article-title":"Subclass Effects on Self-Association and Viscosity of Monoclonal Antibodies at High Concentrations","volume":"20","author":"Chowdhury","year":"2023","journal-title":"Molecular Pharmaceutics"},{"issue":"6","key":"10.1016\/j.addr.2026.115812_bb0280","article-title":"Time Savings with Rituximab Subcutaneous Injection versus Rituximab Intravenous Infusion: A Time and Motion Study in Eight Countries","volume":"11","author":"Cock","year":"2016","journal-title":"PLOS ONE"},{"issue":"4","key":"10.1016\/j.addr.2026.115812_bb0285","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1016\/j.xphs.2021.02.003","article-title":"Overview of Humira\u00ae Biosimilars: Current European Landscape and Future Implications","volume":"110","author":"Coghlan","year":"2021","journal-title":"Journal of Pharmaceutical Sciences"},{"issue":"1","key":"10.1016\/j.addr.2026.115812_bb0290","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.bpj.2012.04.047","article-title":"Weak Interactions Govern the Viscosity of Concentrated Antibody Solutions: High-Throughput Analysis Using the Diffusion Interaction Parameter","volume":"103","author":"Connolly","year":"2012","journal-title":"Biophysical Journal"},{"key":"10.1016\/j.addr.2026.115812_bb0295","series-title":"The Physical and Chemical Basis of Molecular Biology","author":"Creighton","year":"2010"},{"issue":"1","key":"10.1016\/j.addr.2026.115812_bb0300","doi-asserted-by":"crossref","first-page":"2304282","DOI":"10.1080\/19420862.2024.2304282","article-title":"Variable domain mutational analysis to probe the molecular mechanisms of high viscosity of an IgG1 antibody","volume":"16","author":"Dai","year":"2024","journal-title":"mAbs"},{"issue":"4","key":"10.1016\/j.addr.2026.115812_bb0305","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1021\/acs.langmuir.0c02785","article-title":"Monoclonal Antibody Aggregation near Silicone Oil\u2013Water Interfaces","volume":"37","author":"Dandekar","year":"2021","journal-title":"Langmuir"},{"issue":"12","key":"10.1016\/j.addr.2026.115812_bb0310","doi-asserted-by":"crossref","first-page":"4385","DOI":"10.1021\/acs.molpharmaceut.1c00561","article-title":"New Model to Predict the Concentration-Dependent Viscosity of Monoclonal Antibody Solutions","volume":"18","author":"Dandekar","year":"2021","journal-title":"Molecular Pharmaceutics"},{"issue":"11","key":"10.1016\/j.addr.2026.115812_bb0315","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1021\/acsestengg.2c00184","article-title":"Assessing Advances in Anti-fouling Membranes to Improve Process Economics and Sustainability of Water Treatment","volume":"2","author":"Das","year":"2022","journal-title":"ACS ES&T Engineering"},{"issue":"5","key":"10.1016\/j.addr.2026.115812_bb0320","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1016\/j.xphs.2022.01.035","article-title":"Proteins on the Rack: Mechanistic Studies on Protein Particle Formation During Peristaltic Pumping","volume":"111","author":"Deiringer","year":"2022","journal-title":"Journal of Pharmaceutical Sciences"},{"key":"10.1016\/j.addr.2026.115812_bb0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.122216","article-title":"Reaching the breaking point: Effect of tubing characteristics on protein particle formation during peristaltic pumping","volume":"627","author":"Deiringer","year":"2022","journal-title":"International Journal of Pharmaceutics"},{"issue":"12","key":"10.1016\/j.addr.2026.115812_bb0330","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1016\/j.xphs.2022.08.037","article-title":"Modification of Tubings for Peristaltic Pumping of Biopharmaceutics","volume":"111","author":"Deiringer","year":"2022","journal-title":"Journal of Pharmaceutical Sciences"},{"issue":"6","key":"10.1016\/j.addr.2026.115812_bb0335","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/j.xphs.2022.02.013","article-title":"Catching Speedy Gonzales: Driving forces for Protein Film Formation on Silicone Rubber Tubing During Pumping","volume":"111","author":"Deiringer","year":"2022","journal-title":"Journal of Pharmaceutical Sciences"},{"issue":"12","key":"10.1016\/j.addr.2026.115812_bb0340","doi-asserted-by":"crossref","first-page":"3579","DOI":"10.1016\/j.xphs.2020.09.014","article-title":"Comparison of Strategies in Development and Manufacturing of Low Viscosity, Ultra-High Concentration Formulation for IgG1 Antibody","volume":"109","author":"Deokar","year":"2020","journal-title":"Journal of Pharmaceutical Sciences"},{"issue":"5","key":"10.1016\/j.addr.2026.115812_bb0345","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1002\/jps.23947","article-title":"Cross-Linked Silicone Coating: A Novel Prefilled Syringe Technology That Reduces Subvisible Particles and Maintains Compatibility with Biologics","volume":"103","author":"Depaz","year":"2014","journal-title":"Journal of Pharmaceutical Sciences"},{"issue":"12","key":"10.1016\/j.addr.2026.115812_bb0350","doi-asserted-by":"crossref","first-page":"3932","DOI":"10.1016\/j.xphs.2019.09.001","article-title":"Mixing of a mAb Formulation in a New Magnetically Coupled Single-Use Mixing System: Key Learnings of Preliminary Experimental and Computational Evaluation","volume":"108","author":"Desai","year":"2019","journal-title":"Journal of Pharmaceutical Sciences"},{"issue":"5","key":"10.1016\/j.addr.2026.115812_bb0355","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1208\/s12249-015-0288-y","article-title":"Tolerability of High-Volume Subcutaneous Injections of a Viscous Placebo Buffer: A Randomized, Crossover Study in Healthy Subjects","volume":"16","author":"Dias","year":"2015","journal-title":"AAPS PharmSciTech"},{"issue":"1","key":"10.1016\/j.addr.2026.115812_bb0360","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/jat.727","article-title":"A good practice guide to the administration of substances and removal of blood, including routes and volumes","volume":"21","author":"Diehl","year":"2001","journal-title":"Journal of Applied Toxicology"},{"issue":"9","key":"10.1016\/j.addr.2026.115812_bb0365","doi-asserted-by":"crossref","first-page":"4673","DOI":"10.1021\/acs.molpharmaceut.4c00609","article-title":"Predicting the Long-Term Stability of Biologics with Short-Term Data","volume":"21","author":"Dillon","year":"2024","journal-title":"Molecular Pharmaceutics"},{"issue":"4","key":"10.1016\/j.addr.2026.115812_bb0370","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1002\/bit.24377","article-title":"Single pass tangential flow filtration to debottleneck downstream processing for therapeutic antibody production","volume":"109","author":"Dizon-Maspat","year":"2012","journal-title":"Biotechnology and Bioengineering"},{"issue":"0","key":"10.1016\/j.addr.2026.115812_bb0375","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1039\/CT9119901554","article-title":"CLXXVII.\u2014The osmotic pressure and conductivity of aqueous solutions of congo-red, and reversible membrane equilibria","volume":"99","author":"Donnan","year":"1911","journal-title":"Journal of the Chemical Society, Transactions"},{"key":"10.1016\/j.addr.2026.115812_bb0380","article-title":"Addressing the Challenges of Viscous Injectable Administration","author":"Donnelly","year":"2021","journal-title":"ONdrugDelivery"},{"issue":"4","key":"10.1016\/j.addr.2026.115812_bb0385","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1080\/19420862.2019.1599634","article-title":"Process optimization and protein engineering mitigated manufacturing challenges of a monoclonal antibody with liquid-liquid phase separation issue by disrupting inter-molecule electrostatic interactions","volume":"11","author":"Du","year":"2019","journal-title":"mAbs"},{"issue":"7","key":"10.1016\/j.addr.2026.115812_bb0390","doi-asserted-by":"crossref","first-page":"1800062","DOI":"10.1002\/biot.201800062","article-title":"Impact of Cavitation, High Shear Stress and Air\/Liquid Interfaces on Protein Aggregation","volume":"13","author":"Duerkop","year":"2018","journal-title":"Biotechnology Journal"},{"issue":"3","key":"10.1016\/j.addr.2026.115812_bb0395","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1016\/S0006-3495(00)76411-3","article-title":"High Apparent Dielectric Constants in the Interior of a Protein Reflect Water Penetration","volume":"79","author":"Dwyer","year":"2000","journal-title":"Biophysical Journal"},{"issue":"4","key":"10.1016\/j.addr.2026.115812_bb0400","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1039\/D1CB00067E","article-title":"Aggregation of protein therapeutics enhances their immunogenicity: Causes and mitigation strategies","volume":"2","author":"Lundahl","year":"2021","journal-title":"RSC Chemical Biology"},{"issue":"2","key":"10.1016\/j.addr.2026.115812_bb0405","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0376-7388(98)00078-7","article-title":"A novel approach for modeling concentration polarization in crossflow membrane filtration based on the equivalence of osmotic pressure model and filtration theory","volume":"145","author":"Elimelech","year":"1998","journal-title":"Journal of Membrane Science"},{"issue":"17","key":"10.1016\/j.addr.2026.115812_bb0410","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1016\/j.vaccine.2016.11.102","article-title":"Vaccine vial monitor availability and use in low- and middle-income countries: A systematic review","volume":"35","author":"Eriksson","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2026.115812_bb0415","doi-asserted-by":"crossref","DOI":"10.1101\/2025.04.06.646989","article-title":"Temperature and Excipient Mediated Modulation of Monoclonal Antibody Interactions Revealed by k D, Rheology, and Raman Spectroscopy","author":"Eskens","year":"2025","journal-title":"Biophysics"},{"issue":"2","key":"10.1016\/j.addr.2026.115812_bb0420","doi-asserted-by":"crossref","first-page":"375","DOI":"10.3390\/pharmaceutics14020375","article-title":"Long-Term Stability Prediction for Developability Assessment of Biopharmaceutics Using Advanced Kinetic Modeling","volume":"14","author":"Evers","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.addr.2026.115812_bb0425","series-title":"Cuvitru Prescribing Information","author":"FDA","year":"2016"},{"key":"10.1016\/j.addr.2026.115812_bb0430","series-title":"Darzalex Faspro Prescribing Information","author":"FDA","year":"2020"},{"key":"10.1016\/j.addr.2026.115812_bb0435","series-title":"Dupixent Prescribing Information","author":"FDA","year":"2017"},{"key":"10.1016\/j.addr.2026.115812_bb0440","series-title":"Enbrel Prescribing Information","author":"FDA","year":"1998"},{"key":"10.1016\/j.addr.2026.115812_bb0445","series-title":"Eylea Prescribing Information","author":"FDA","year":"2011"},{"key":"10.1016\/j.addr.2026.115812_bb0450","series-title":"Herceptin Hylecta Prescribing Information","author":"FDA","year":"2019"},{"key":"10.1016\/j.addr.2026.115812_bb0455","series-title":"Hizentra Prescribing Information","author":"FDA","year":"2010"},{"key":"10.1016\/j.addr.2026.115812_bb0460","series-title":"Humira Prescribing Information","author":"FDA","year":"2002"},{"key":"10.1016\/j.addr.2026.115812_bb0465","series-title":"Lucentis Prescribing Information","author":"FDA","year":"2006"},{"key":"10.1016\/j.addr.2026.115812_bb0470","series-title":"Phesgo Prescribing Information","author":"FDA","year":"2020"},{"key":"10.1016\/j.addr.2026.115812_bb0475","series-title":"Praluent Prescribing Information","author":"FDA","year":"2015"},{"key":"10.1016\/j.addr.2026.115812_bb0480","series-title":"Repatha Prescribing Information","author":"FDA","year":"2015"},{"key":"10.1016\/j.addr.2026.115812_bb0485","series-title":"Rituxan Hycela Prescribing Information","author":"FDA","year":"2017"},{"key":"10.1016\/j.addr.2026.115812_bb0490","doi-asserted-by":"crossref","DOI":"10.1016\/j.memsci.2019.117606","article-title":"The prediction of the operating conditions on the permeate flux and on protein aggregation during membrane processing of monoclonal antibodies","volume":"596","author":"Fernandez-Cerezo","year":"2020","journal-title":"Journal of Membrane Science"},{"issue":"2","key":"10.1016\/j.addr.2026.115812_bb0495","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3390\/membranes12020187","article-title":"Permeate Flux in Ultrafiltration Processes\u2014Understandings and Misunderstandings","volume":"12","author":"Field","year":"2022","journal-title":"Membranes"},{"key":"10.1016\/j.addr.2026.115812_bb0500","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2025.107113","article-title":"Antibody oxidation and impact of formulation: A high-throughput screening approach","volume":"209","author":"Fischer","year":"2025","journal-title":"European Journal of Pharmaceutical Sciences"},{"issue":"4","key":"10.1016\/j.addr.2026.115812_bb0505","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1517\/17425247.4.4.427","article-title":"Recombinant human hyaluronidase (rHuPH20): An enabling platform for subcutaneous drug and fluid administration","volume":"4","author":"Frost","year":"2007","journal-title":"Expert Opinion on Drug Delivery"},{"key":"10.1016\/j.addr.2026.115812_bb0510","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ejpb.2022.08.008","article-title":"Viscosity increase\/gelation of therapeutic IgG monoclonal antibodies induced by Zn2+: One possible root cause of clogging of staked-in-needle prefilled syringes","volume":"178","author":"Fukuda","year":"2022","journal-title":"European Journal of Pharmaceutics and Biopharmaceutics"},{"key":"10.1016\/j.addr.2026.115812_bb0515","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.ejpb.2017.06.029","article-title":"High-concentration protein formulations: How high is high?","volume":"119","author":"Garidel","year":"2017","journal-title":"European Journal of Pharmaceutics and Biopharmaceutics"},{"issue":"6","key":"10.1016\/j.addr.2026.115812_bb0520","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1002\/jps.23973","article-title":"Protein Aggregation and Particle Formation in Prefilled Glass Syringes","volume":"103","author":"Gerhardt","year":"2014","journal-title":"Journal of Pharmaceutical Sciences"},{"issue":"1","key":"10.1016\/j.addr.2026.115812_bb0525","doi-asserted-by":"crossref","first-page":"2205540","DOI":"10.1080\/19420862.2023.2205540","article-title":"A systematic review of commercial high concentration antibody drug products approved in the US: Formulation composition, dosage form design and primary packaging considerations","volume":"15","author":"Ghosh","year":"2023","journal-title":"mAbs"},{"issue":"3","key":"10.1016\/j.addr.2026.115812_bb0530","doi-asserted-by":"crossref","first-page":"46","DOI":"10.3390\/membranes8030046","article-title":"Concentration Polarization in Ultrafiltration\/Nanofiltration for the Recovery of Polyphenols from Winery Wastewaters","volume":"8","author":"Giacobbo","year":"2018","journal-title":"Membranes"},{"issue":"8","key":"10.1016\/j.addr.2026.115812_bb0535","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1016\/j.xphs.2020.03.024","article-title":"A Review on Mixing-Induced Protein Particle Formation: The Puzzle of Bottom-Mounted Mixers","volume":"109","author":"Gikanga","year":"2020","journal-title":"Journal of Pharmaceutical Sciences"},{"issue":"2","key":"10.1016\/j.addr.2026.115812_bb0540","doi-asserted-by":"crossref","first-page":"284","DOI":"10.5731\/pdajpst.2015.01031","article-title":"Mixing monoclonal antibody formulations using bottom-mounted mixers: Impact of mechanism and design on drug product quality","volume":"69","author":"Gikanga","year":"2015","journal-title":"PDA Journal of Pharmaceutical Science and Technology"},{"issue":"2","key":"10.1016\/j.addr.2026.115812_bb0545","doi-asserted-by":"crossref","first-page":"117","DOI":"10.5731\/pdajpst.2017.007732","article-title":"Mechanistic Investigation on Grinding-Induced Subvisible Particle Formation during Mixing and Filling of Monoclonal Antibody Formulations","volume":"72","author":"Gikanga","year":"2018","journal-title":"PDA Journal of Pharmaceutical Science and Technology"},{"issue":"2","key":"10.1016\/j.addr.2026.115812_bb0550","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1021\/acs.jpcb.5b07260","article-title":"Effect of Hierarchical Cluster Formation on the Viscosity of Concentrated Monoclonal Antibody Formulations Studied by Neutron Scattering","volume":"120","author":"Godfrin","year":"2016","journal-title":"The Journal of Physical Chemistry B"},{"issue":"8","key":"10.1016\/j.addr.2026.115812_bb0555","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1002\/jps.21232","article-title":"Self-Buffering Antibody Formulations","volume":"97","author":"Gokarn","year":"2008","journal-title":"Journal of Pharmaceutical Sciences"},{"issue":"11","key":"10.1016\/j.addr.2026.115812_bb0560","doi-asserted-by":"crossref","first-page":"3558","DOI":"10.1016\/j.xphs.2021.06.033","article-title":"Identification and Characterization of Polysorbate-Degrading Enzymes in a Monoclonal Antibody Formulation","volume":"110","author":"Graf","year":"2021","journal-title":"Journal of Pharmaceutical Sciences"},{"issue":"8","key":"10.1016\/j.addr.2026.115812_bb0565","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1016\/j.xphs.2020.03.010","article-title":"Protein-Polydimethylsiloxane Particles in Liquid Vial Monoclonal Antibody Formulations Containing Poloxamer 188","volume":"109","author":"Grapentin","year":"2020","journal-title":"Journal of Pharmaceutical Sciences"},{"issue":"12","key":"10.1016\/j.addr.2026.115812_bb0570","doi-asserted-by":"crossref","first-page":"3596","DOI":"10.1002\/bit.28239","article-title":"Machine learning approaches to root cause analysis, characterization, and monitoring of subvisible particles in monoclonal antibody formulations","volume":"119","author":"Greenblott","year":"2022","journal-title":"Biotechnology and Bioengineering"},{"issue":"11","key":"10.1016\/j.addr.2026.115812_bb0575","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.it.2007.07.011","article-title":"Immunogenicity of protein therapeutics","volume":"28","author":"Groot","year":"2007","journal-title":"Trends in Immunology"},{"issue":"4","key":"10.1016\/j.addr.2026.115812_bb0580","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.xphs.2021.11.024","article-title":"Oxidation and Deamidation of Monoclonal Antibody Products: Potential Impact on Stability, Biological Activity, and Efficacy","volume":"111","author":"Gupta","year":"2022","journal-title":"Journal of Pharmaceutical Sciences"},{"key":"10.1016\/j.addr.2026.115812_bb0585","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ejpb.2019.12.010","article-title":"Impact of dextran on thermal properties, product quality attributes, and monoclonal antibody stability in freeze-dried formulations","volume":"147","author":"Haeuser","year":"2020","journal-title":"European Journal of Pharmaceutics and Biopharmaceutics"},{"issue":"3","key":"10.1016\/j.addr.2026.115812_bb0590","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/j.xphs.2018.10.031","article-title":"Syringe Filling of a High-Concentration mAb Formulation: Experimental, Theoretical, and Computational Evaluation of Filling Process Parameters That Influence the Propensity for Filling Needle Clogging","volume":"108","author":"Hanslip","year":"2019","journal-title":"Journal of Pharmaceutical Sciences"},{"issue":"3","key":"10.1016\/j.addr.2026.115812_bb0595","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1002\/jps.20753","article-title":"Highly Concentrated Monoclonal Antibody Solutions: Direct Analysis of Physical Structure and Thermal Stability","volume":"96","author":"Harn","year":"2007","journal-title":"Journal of Pharmaceutical Sciences"},{"issue":"2","key":"10.1016\/j.addr.2026.115812_bb0600","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s40259-023-00641-2","article-title":"Reducing Immunogenicity by Design: Approaches to Minimize Immunogenicity of Monoclonal Antibodies","volume":"38","author":"Harris","year":"2024","journal-title":"BioDrugs"},{"issue":"2","key":"10.1016\/j.addr.2026.115812_bb0605","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1021\/acs.molpharmaceut.1c00587","article-title":"Dipolar Interactions and Protein Hydration in Highly Concentrated Antibody Formulations","volume":"19","author":"Hartl","year":"2022","journal-title":"Molecular Pharmaceutics"},{"issue":"5","key":"10.1016\/j.addr.2026.115812_bb0610","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s11095-018-2378-5","article-title":"Impact of Buffer, Protein Concentration and Sucrose Addition on the Aggregation and Particle Formation during Freezing and Thawing","volume":"35","author":"Hauptmann","year":"2018","journal-title":"Pharmaceutical Research"},{"issue":"4","key":"10.1016\/j.addr.2026.115812_bb0615","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1002\/jps.22384","article-title":"Screening of Monoclonal Antibody Formulations Based on High-Throughput Thermostability and Viscosity Measurements: Design of Experiment and Statistical Analysis","volume":"100","author":"He","year":"2011","journal-title":"Journal of Pharmaceutical Sciences"},{"key":"10.1016\/j.addr.2026.115812_bb0620","doi-asserted-by":"crossref","DOI":"10.1016\/j.seppur.2019.116392","article-title":"Modeling and prediction of excipient and pH drifts during ultrafiltration\/diafiltration of monoclonal antibody biotherapeutic for high concentration formulations","volume":"238","author":"Hebbi","year":"2020","journal-title":"Separation and Purification Technology"},{"issue":"1","key":"10.1016\/j.addr.2026.115812_bb0625","doi-asserted-by":"crossref","first-page":"2379560","DOI":"10.1080\/19420862.2024.2379560","article-title":"Modulation of the high concentration viscosity of IgG1 antibodies using clinically validated Fc mutations","volume":"16","author":"Heisler","year":"2024","journal-title":"mAbs"},{"issue":"4","key":"10.1016\/j.addr.2026.115812_bb0630","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.xphs.2020.01.009","article-title":"Effects of Tubing Type, Operating Parameters, and Surfactants on Particle Formation During Peristaltic Filling Pump Processing of a mAb Formulation","volume":"109","author":"Her","year":"2020","journal-title":"Journal of Pharmaceutical Sciences"},{"issue":"1","key":"10.1016\/j.addr.2026.115812_bb0635","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1063\/1.1729949","article-title":"Theory of solutions. II. Osmotic pressure virial expansion and light scattering in two component solutions","volume":"30","author":"Hill","year":"1959","journal-title":"The Journal of Chemical Physics"},{"key":"10.1016\/j.addr.2026.115812_bb0640","series-title":"Jet injection of a monoclonal antibody: A preliminary study. 2015 37th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC), 7336\u20137340","author":"Hogan","year":"2015"},{"issue":"11","key":"10.1016\/j.addr.2026.115812_bb0645","doi-asserted-by":"crossref","first-page":"3591","DOI":"10.1002\/bit.27510","article-title":"Strategies for high-concentration drug substance manufacturing to facilitate subcutaneous administration: A review","volume":"117","author":"Holstein","year":"2020","journal-title":"Biotechnology and Bioengineering"},{"issue":"5","key":"10.1016\/j.addr.2026.115812_bb0650","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1213\/01.ANE.0000055820.56129.EE","article-title":"Physiologic Effects of Intravenous Fluid Administration in Healthy Volunteers","volume":"96","author":"Holte","year":"2003","journal-title":"Anesthesia & Analgesia"},{"issue":"20","key":"10.1016\/j.addr.2026.115812_bb0655","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1080\/10826076.2012.743724","article-title":"A REVIEW SIZE-EXCLUSION CHROMATOGRAPHY FOR THE ANALYSIS OF PROTEIN BIOTHERAPEUTICS AND THEIR AGGREGATES","volume":"35","author":"Hong","year":"2012","journal-title":"Journal of Liquid Chromatography & Related Technologies"},{"key":"10.1016\/j.addr.2026.115812_bb0660","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2022.120349","article-title":"The influence of excipients on the viscosity of monoclonal antibody solutions","volume":"366","author":"Hribar-Lee","year":"2022","journal-title":"Journal of Molecular Liquids"},{"issue":"9","key":"10.1016\/j.addr.2026.115812_bb0665","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1080\/10837450.2022.2131818","article-title":"Recent advances and persistent challenges in the design of freeze-drying process for monoclonal antibodies","volume":"27","author":"Hsein","year":"2022","journal-title":"Pharmaceutical Development and Technology"},{"issue":"1","key":"10.1016\/j.addr.2026.115812_bb0670","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.xphs.2019.06.005","article-title":"Characterization of Excipient Effects on Reversible Self-Association, Backbone Flexibility, and Solution Properties of an IgG1 Monoclonal Antibody at High Concentrations: Part 1","volume":"109","author":"Hu","year":"2020","journal-title":"Journal of Pharmaceutical Sciences"},{"key":"10.1016\/j.addr.2026.115812_bb0675","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.memsci.2016.02.031","article-title":"High concentration tangential flow ultrafiltration of stable monoclonal antibody solutions with low viscosities","volume":"508","author":"Hung","year":"2016","journal-title":"Journal of Membrane Science"},{"key":"10.1016\/j.addr.2026.115812_bb0680","first-page":"1","article-title":"Evaluation for stability data. ICH Q1E","volume":"6","author":"Guideline","year":"2003","journal-title":"ICH"},{"issue":"6","key":"10.1016\/j.addr.2026.115812_bb0685","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1021\/mp5000218","article-title":"Specific Decrease in Solution Viscosity of Antibodies by Arginine for Therapeutic Formulations","volume":"11","author":"Inoue","year":"2014","journal-title":"Molecular Pharmaceutics"},{"key":"10.1016\/j.addr.2026.115812_bb0690","doi-asserted-by":"crossref","first-page":"179","DOI":"10.14356\/kona.2016024","article-title":"Developments of Blocking Filtration Model in Membrane Filtration","volume":"33","author":"Iritani","year":"2016","journal-title":"KONA Powder and Particle Journal"},{"issue":"9","key":"10.1016\/j.addr.2026.115812_bb0695","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/S1470-2045(12)70329-7","article-title":"Subcutaneous versus intravenous administration of (neo)adjuvant trastuzumab in patients with HER2-positive, clinical stage I\u2013III breast cancer (HannaH study): A phase 3, open-label, multicentre, randomised trial","volume":"13","author":"Ismael","year":"2012","journal-title":"The Lancet Oncology"},{"key":"10.1016\/j.addr.2026.115812_bb0700","author":"Ito","year":"2016","journal-title":"Bioprocess Single-Use Pressure Rating Testing."},{"key":"10.1016\/j.addr.2026.115812_bb0705","doi-asserted-by":"crossref","DOI":"10.1016\/j.memsci.2021.120047","article-title":"Design and optimization of Single Pass Tangential Flow Filtration for inline concentration of monoclonal antibodies","volume":"643","author":"Jabra","year":"2022","journal-title":"Journal of Membrane Science"},{"key":"10.1016\/j.addr.2026.115812_bb0710","doi-asserted-by":"crossref","DOI":"10.1016\/j.memsci.2021.119606","article-title":"Single Pass Tangential Flow Filtration (SPTFF) of monoclonal antibodies: Experimental studies and theoretical analysis","volume":"637","author":"Jabra","year":"2021","journal-title":"Journal of Membrane Science"},{"issue":"1","key":"10.1016\/j.addr.2026.115812_bb0715","doi-asserted-by":"crossref","first-page":"11332","DOI":"10.1038\/s41598-021-90772-9","article-title":"Freeze\u2013thaw characterization process to minimize aggregation and enable drug product manufacturing of protein based therapeutics","volume":"11","author":"Jain","year":"2021","journal-title":"Scientific Reports"},{"issue":"6","key":"10.1016\/j.addr.2026.115812_bb0720","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1021\/acs.jpcb.3c05303","article-title":"Computational Screening for mAb Colloidal Stability with Coarse-Grained, Molecular-Scale Simulations","volume":"128","author":"Janke","year":"2024","journal-title":"The Journal of Physical Chemistry B"},{"key":"10.1016\/j.addr.2026.115812_bb0725","doi-asserted-by":"crossref","DOI":"10.3389\/fceng.2023.1182817","article-title":"Deep neural network for prediction and control of permeability decline in single pass tangential flow ultrafiltration in continuous processing of monoclonal antibodies","volume":"5","author":"Jesubalan","year":"2023","journal-title":"Frontiers in Chemical Engineering"},{"issue":"13","key":"10.1016\/j.addr.2026.115812_bb0730","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.addr.2011.09.008","article-title":"Viscosity of concentrated therapeutic protein compositions","volume":"63","author":"Jezek","year":"2011","journal-title":"Advanced Drug Delivery Reviews"},{"key":"10.1016\/j.addr.2026.115812_bb0735","first-page":"923","article-title":"The optimal choice of medication administration route regarding intravenous, intramuscular, and subcutaneous injection","volume":"9","author":"Jin","year":"2015","journal-title":"Patient Preference and Adherence"},{"issue":"5","key":"10.1016\/j.addr.2026.115812_bb0740","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.xphs.2023.12.010","article-title":"Freeze Drying and Vial Breakage: Misconceptions, Root Causes and Mitigation Strategies for the Pharmaceutical Industry","volume":"113","author":"Jin","year":"2024","journal-title":"Journal of Pharmaceutical Sciences"},{"issue":"4","key":"10.1016\/j.addr.2026.115812_bb0745","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.xphs.2021.11.008","article-title":"Ongoing Challenges to Develop High Concentration Monoclonal Antibody-based Formulations for Subcutaneous Administration: Quo Vadis?","volume":"111","author":"Jiskoot","year":"2022","journal-title":"Journal of Pharmaceutical Sciences"},{"issue":"4","key":"10.1016\/j.addr.2026.115812_bb0750","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1002\/jps.20321","article-title":"Silicone Oil Induced Aggregation of Proteins","volume":"94","author":"Jones","year":"2005","journal-title":"Journal of Pharmaceutical Sciences"},{"issue":"20","key":"10.1016\/j.addr.2026.115812_bb0755","doi-asserted-by":"crossref","first-page":"4922","DOI":"10.1021\/acs.jpcb.4c00022","article-title":"Comparison of Sucrose and Trehalose for Protein Stabilization Using Differential Scanning Calorimetry","volume":"128","author":"Jonsson","year":"2024","journal-title":"The Journal of Physical Chemistry B"},{"issue":"1","key":"10.1016\/j.addr.2026.115812_bb0760","doi-asserted-by":"crossref","first-page":"2483944","DOI":"10.1080\/19420862.2025.2483944","article-title":"Accelerating high-concentration monoclonal antibody development with large-scale viscosity data and ensemble deep learning","volume":"17","author":"Kalejaye","year":"2025","journal-title":"mAbs"},{"issue":"3","key":"10.1016\/j.addr.2026.115812_bb0765","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.xphs.2022.10.028","article-title":"Predicting Formulation Conditions During Ultrafiltration and Dilution to Drug Substance Using a Donnan Model with Homology-Model Based Protein Charge","volume":"112","author":"Kannan","year":"2023","journal-title":"Journal of Pharmaceutical Sciences"},{"key":"10.1016\/j.addr.2026.115812_bb0770","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jcis.2019.04.060","article-title":"Linking aggregation and interfacial properties in monoclonal antibody-surfactant formulations","volume":"550","author":"Kannan","year":"2019","journal-title":"Journal of Colloid and Interface Science"},{"issue":"9","key":"10.1016\/j.addr.2026.115812_bb0775","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.1021\/acs.molpharmaceut.2c00152","article-title":"Differential Surface Adsorption Phenomena for Conventional and Novel Surfactants Correlates with Changes in Interfacial mAb Stabilization","volume":"19","author":"Kanthe","year":"2022","journal-title":"Molecular Pharmaceutics"},{"issue":"2","key":"10.1016\/j.addr.2026.115812_bb0780","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1002\/btpr.1682","article-title":"Buffer capacity of biologics\u2014From buffer salts to buffering by antibodies","volume":"29","author":"Karow","year":"2013","journal-title":"Biotechnology Progress"},{"issue":"6","key":"10.1016\/j.addr.2026.115812_bb0785","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1080\/14760584.2022.2061462","article-title":"Ensuring quality and integrity of vaccines throughout the cold chain: The role of temperature monitoring","volume":"21","author":"Kartoglu","year":"2022","journal-title":"Expert Review of Vaccines"},{"issue":"10","key":"10.1016\/j.addr.2026.115812_bb0790","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.3390\/pharmaceutics16101346","article-title":"Effectiveness of Lyoprotectants in Protein Stabilization During Lyophilization","volume":"16","author":"Karunnanithy","year":"2024","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.addr.2026.115812_bb0795","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1021\/acs.molpharmaceut.8b00984","article-title":"Dynamic Properties of Novel Excipient Suggest Mechanism for Improved Performance in Liquid Stabilization of Protein Biologics","volume":"16","author":"Katz","year":"2019","journal-title":"Molecular Pharmaceutics"},{"issue":"8","key":"10.1016\/j.addr.2026.115812_bb0800","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1002\/bit.28420","article-title":"Fouling of virus filtration membranes by monoclonal antibody feeds with low aggregate content","volume":"121","author":"Kaufman","year":"2024","journal-title":"Biotechnology and Bioengineering"},{"issue":"1","key":"10.1016\/j.addr.2026.115812_bb0805","doi-asserted-by":"crossref","first-page":"2373330","DOI":"10.1080\/19420862.2024.2373330","article-title":"The history and potential future of monoclonal antibody therapeutics development and manufacturing in four eras","volume":"16","author":"Kelley","year":"2024","journal-title":"mAbs"},{"issue":"7","key":"10.1016\/j.addr.2026.115812_bb0810","doi-asserted-by":"crossref","first-page":"1700523","DOI":"10.1002\/biot.201700523","article-title":"Amino Acid-Based Advanced Liquid Formulation Development for Highly Concentrated Therapeutic Antibodies Balances Physical and Chemical Stability and Low Viscosity","volume":"13","author":"Kemter","year":"2018","journal-title":"Biotechnology Journal"},{"issue":"1\u20132","key":"10.1016\/j.addr.2026.115812_bb0815","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ijpharm.2014.06.053","article-title":"The effect of arginine glutamate on the stability of monoclonal antibodies in solution","volume":"473","author":"Kheddo","year":"2014","journal-title":"International Journal of Pharmaceutics"},{"issue":"1","key":"10.1016\/j.addr.2026.115812_bb0820","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2022.103415","article-title":"Monoclonal antibodies: Trends in therapeutic success and commercial focus","volume":"28","author":"Kinch","year":"2023","journal-title":"Drug Discovery Today"},{"issue":"1","key":"10.1016\/j.addr.2026.115812_bb0825","doi-asserted-by":"crossref","first-page":"2200102","DOI":"10.1002\/adtp.202200102","article-title":"Stable High-Concentration Monoclonal Antibody Formulations Enabled by an Amphiphilic Copolymer Excipient","volume":"6","author":"Klich","year":"2023","journal-title":"Advanced Therapeutics"},{"issue":"3","key":"10.1016\/j.addr.2026.115812_bb0830","doi-asserted-by":"crossref","first-page":"rqae018","DOI":"10.1093\/rpsppr\/rqae018","article-title":"Stress factors affecting protein stability during the fabrication and storage of dissolvable microneedles","volume":"3","author":"Koenitz","year":"2024","journal-title":"RPS Pharmacy and Pharmacology Reports"},{"key":"10.1016\/j.addr.2026.115812_bb0835","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ddtec.2020.08.005","article-title":"Development challenges of high concentration monoclonal antibody formulations","volume":"37","author":"Koll\u00e1r","year":"2020","journal-title":"Drug Discovery Today: Technologies"},{"issue":"10","key":"10.1016\/j.addr.2026.115812_bb0840","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.105127","article-title":"Freeze-drying for the preservation of immunoengineering products","volume":"25","author":"Kommineni","year":"2022","journal-title":"iScience"},{"key":"10.1016\/j.addr.2026.115812_bb0845","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ejpb.2018.07.014","article-title":"Buffer exchange path influences the stability and viscosity upon storage of a high concentration protein","volume":"131","author":"Krause","year":"2018","journal-title":"European Journal of Pharmaceutics and Biopharmaceutics"},{"issue":"4","key":"10.1016\/j.addr.2026.115812_bb0850","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1208\/s12248-025-01078-x","article-title":"Removal of Excipients from Drug Product may Impact Antibody Characterization of Monoclonal Antibodies","volume":"27","author":"Krishna","year":"2025","journal-title":"The AAPS Journal"},{"issue":"2","key":"10.1016\/j.addr.2026.115812_bb0855","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s12247-019-09423-2","article-title":"Product-Related Factors and Immunogenicity of Biotherapeutics","volume":"15","author":"Krishna","year":"2020","journal-title":"Journal of Pharmaceutical Innovation"},{"issue":"10","key":"10.1016\/j.addr.2026.115812_bb0860","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1016\/j.xphs.2020.05.029","article-title":"Reconstitution Time for Highly Concentrated Lyophilized Proteins: Role of Formulation and Protein","volume":"109","author":"Kulkarni","year":"2020","journal-title":"Journal of Pharmaceutical Sciences"},{"issue":"21","key":"10.1016\/j.addr.2026.115812_bb0865","doi-asserted-by":"crossref","DOI":"10.1002\/app.42042","article-title":"Fouling control on microfiltration\/ultrafiltration membranes: Effects of morphology, hydrophilicity, and charge","volume":"132","author":"Kumar","year":"2015","journal-title":"Journal of Applied Polymer Science"},{"issue":"1","key":"10.1016\/j.addr.2026.115812_bb0870","doi-asserted-by":"crossref","first-page":"20534","DOI":"10.1038\/s41598-021-99875-9","article-title":"Long-term stability predictions of therapeutic monoclonal antibodies in solution using Arrhenius-based kinetics","volume":"11","author":"Kuzman","year":"2021","journal-title":"Scientific Reports"},{"issue":"3","key":"10.1016\/j.addr.2026.115812_bb0875","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1021\/acs.molpharmaceut.0c01073","article-title":"Machine Learning Applied to Determine the Molecular Descriptors Responsible for the Viscosity Behavior of Concentrated Therapeutic Antibodies","volume":"18","author":"Lai","year":"2021","journal-title":"Molecular Pharmaceutics"},{"issue":"4","key":"10.1016\/j.addr.2026.115812_bb0880","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/j.xphs.2020.12.014","article-title":"Machine Learning Feature Selection for Predicting High Concentration Therapeutic Antibody Aggregation","volume":"110","author":"Lai","year":"2021","journal-title":"Journal of Pharmaceutical Sciences"},{"issue":"1","key":"10.1016\/j.addr.2026.115812_bb0885","doi-asserted-by":"crossref","first-page":"2026208","DOI":"10.1080\/19420862.2022.2026208","article-title":"Machine learning prediction of antibody aggregation and viscosity for high concentration formulation development of protein therapeutics","volume":"14","author":"Lai","year":"2022","journal-title":"mAbs"},{"issue":"3","key":"10.1016\/j.addr.2026.115812_bb0890","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1021\/ed058p250","article-title":"Motion in viscous liquids: Simplified derivations of the Stokes and Einstein equations","volume":"58","author":"Lauffer","year":"1981","journal-title":"Journal of Chemical Education"},{"issue":"1","key":"10.1016\/j.addr.2026.115812_bb0895","first-page":"42","volume":"2","author":"Lazar","year":"2010","journal-title":"Cold denaturation of monoclonal antibodies. mAbs"},{"issue":"1","key":"10.1016\/j.addr.2026.115812_bb0900","doi-asserted-by":"crossref","first-page":"2543771","DOI":"10.1080\/19420862.2025.2543771","article-title":"Enhanced rational protein engineering to reduce viscosity in high-concentration IgG1 antibody solutions","volume":"17","author":"Lefevre","year":"2025","journal-title":"mAbs"},{"issue":"8","key":"10.1016\/j.addr.2026.115812_bb0905","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1007\/s00216-022-03913-y","article-title":"Structural identification and absolute quantification of monoclonal antibodies in suspected counterfeits using capillary electrophoresis and liquid chromatography-tandem mass spectrometry","volume":"414","author":"Legrand","year":"2022","journal-title":"Analytical and Bioanalytical Chemistry"},{"issue":"2","key":"10.1016\/j.addr.2026.115812_bb0910","doi-asserted-by":"crossref","DOI":"10.1063\/5.0201626","article-title":"The viscoelasticity of high concentration monoclonal antibodies using particle tracking microrheology","volume":"8","author":"Lewis","year":"2024","journal-title":"APL Bioengineering"},{"issue":"3","key":"10.1016\/j.addr.2026.115812_bb0915","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1208\/s12248-019-0312-3","article-title":"Interfacial Stress in the Development of Biologics: Fundamental Understanding, Current Practice, and Future Perspective","volume":"21","author":"Li","year":"2019","journal-title":"The AAPS Journal"},{"issue":"11","key":"10.1016\/j.addr.2026.115812_bb0920","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.1007\/s11095-014-1409-0","article-title":"Concentration Dependent Viscosity of Monoclonal Antibody Solutions: Explaining Experimental Behavior in Terms of Molecular Properties","volume":"31","author":"Li","year":"2014","journal-title":"Pharmaceutical Research"},{"issue":"4","key":"10.1016\/j.addr.2026.115812_bb0925","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1021\/ct400065j","article-title":"On the Dielectric \u201cConstant\u201d of Proteins: Smooth Dielectric Function for Macromolecular Modeling and Its Implementation in DelPhi","volume":"9","author":"Li","year":"2013","journal-title":"Journal of Chemical Theory and Computation"},{"issue":"1","key":"10.1016\/j.addr.2026.115812_bb0930","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1093\/abt\/tbac002","article-title":"The measurement and control of high-risk host cell proteins for polysorbate degradation in biologics formulation","volume":"5","author":"Li","year":"2022","journal-title":"Antibody Therapeutics"},{"issue":"21","key":"10.1016\/j.addr.2026.115812_bb0935","doi-asserted-by":"crossref","first-page":"6373","DOI":"10.1021\/jp4008152","article-title":"Monoclonal Antibody Self-Association, Cluster Formation, and Rheology at High Concentrations","volume":"117","author":"Lilyestrom","year":"2013","journal-title":"The Journal of Physical Chemistry B"},{"issue":"7","key":"10.1016\/j.addr.2026.115812_bb0940","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1080\/01496391003666940","article-title":"Membrane Fouling Mitigation: Membrane Cleaning","volume":"45","author":"Lin","year":"2010","journal-title":"Separation Science and Technology"},{"issue":"5","key":"10.1016\/j.addr.2026.115812_bb0945","doi-asserted-by":"crossref","first-page":"480","DOI":"10.4161\/mabs.2.5.12645","article-title":"Recovery and purification process development for monoclonal antibody production","volume":"2","author":"Liu","year":"2010","journal-title":"mAbs"},{"issue":"12","key":"10.1016\/j.addr.2026.115812_bb0950","doi-asserted-by":"crossref","first-page":"6484","DOI":"10.1021\/acs.molpharmaceut.4c01174","article-title":"\u201cThe More, the Better?\u201d: The Impact of Sugar-to-Protein Molar Ratio in Freeze-Dried Monoclonal Antibody Formulations on Protein Stability","volume":"21","author":"Lo Presti","year":"2024","journal-title":"Molecular Pharmaceutics"},{"issue":"1","key":"10.1016\/j.addr.2026.115812_bb0955","doi-asserted-by":"crossref","first-page":"2471465","DOI":"10.1080\/19420862.2025.2471465","article-title":"Prediction of long-term stability of high-concentration formulations to support rapid development of antibodies against SARS-CoV-2","volume":"17","author":"Luo","year":"2025","journal-title":"mAbs"},{"key":"10.1016\/j.addr.2026.115812_bb0960","series-title":"High-Concentration UF\/DF of a Monoclonal Antibody","author":"Luo","year":"2006"},{"key":"10.1016\/j.addr.2026.115812_bb0965","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124472","article-title":"Histidine as a versatile excipient in the protein-based biopharmaceutical formulations","volume":"662","author":"Lv","year":"2024","journal-title":"International Journal of Pharmaceutics"},{"key":"10.1016\/j.addr.2026.115812_bb0970","doi-asserted-by":"crossref","DOI":"10.1016\/j.seppur.2022.120949","article-title":"Single pass tangential flow filtration: Critical operational variables, fouling, and main current applications","volume":"291","author":"Madsen","year":"2022","journal-title":"Separation and Purification Technology"},{"key":"10.1016\/j.addr.2026.115812_bb0975","series-title":"Novel Excipients Prevent Aggregation in Manufacturing and Formulation of Protein and Peptide Therapeutics","author":"Maggio","year":"2008"},{"issue":"3","key":"10.1016\/j.addr.2026.115812_bb0980","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.ejpb.2004.12.004","article-title":"Induction and analysis of aggregates in a liquid IgG1-antibody formulation","volume":"59","author":"Mahler","year":"2005","journal-title":"European Journal of Pharmaceutics and Biopharmaceutics"},{"issue":"6","key":"10.1016\/j.addr.2026.115812_bb0985","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1182\/blood.V90.6.2188","article-title":"IDEC-C2B8 (Rituximab) Anti-CD20 Monoclonal Antibody Therapy in Patients With Relapsed Low-Grade Non-Hodgkin\u2019s Lymphoma","volume":"90","author":"Maloney","year":"1997","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.addr.2026.115812_bb0990","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1002\/btpr.1567","article-title":"State-of-the-art in downstream processing of monoclonal antibodies: Process trends in design and validation","volume":"28","author":"Marichal-Gallardo","year":"2012","journal-title":"Biotechnology Progress"},{"issue":"1","key":"10.1016\/j.addr.2026.115812_bb0995","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.xphs.2019.10.013","article-title":"Novel High-Throughput Assay for Polysorbate Quantification in Biopharmaceutical Products by Using the Fluorescent Dye DiI","volume":"109","author":"Martos","year":"2020","journal-title":"Journal of Pharmaceutical Sciences"},{"issue":"10","key":"10.1016\/j.addr.2026.115812_bb1000","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.tibtech.2020.07.004","article-title":"Process Analytical Technologies and Data Analytics for the Manufacture of Monoclonal Antibodies","volume":"38","author":"Maruthamuthu","year":"2020","journal-title":"Trends in Biotechnology"},{"issue":"10","key":"10.1016\/j.addr.2026.115812_bb1005","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1016\/j.xphs.2018.06.021","article-title":"Liquid Droplet of Protein-Polyelectrolyte Complex for High-Concentration Formulations","volume":"107","author":"Matsuda","year":"2018","journal-title":"Journal of Pharmaceutical Sciences"},{"key":"10.1016\/j.addr.2026.115812_bb1010","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.bpc.2013.09.005","article-title":"Interpretation of negative second virial coefficients from non-attractive protein solution osmotic pressure data: An alternate perspective","volume":"184","author":"MBride","year":"2013","journal-title":"Biophysical Chemistry"},{"issue":"6","key":"10.1016\/j.addr.2026.115812_bb1015","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1208\/s12249-022-02360-3","article-title":"Environmental Monitoring for Closed Robotic Workcells Used in Aseptic Processing: Data to Support Advanced Environmental Monitoring Strategies","volume":"23","author":"McCall","year":"2022","journal-title":"AAPS PharmSciTech"},{"issue":"6","key":"10.1016\/j.addr.2026.115812_bb1020","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1208\/s12248-021-00641-6","article-title":"Considerations for Updates to ICH Q1 and Q5C Stability Guidelines: Embracing Current Technology and Risk Assessment Strategies","volume":"23","author":"McMahon","year":"2021","journal-title":"The AAPS Journal"},{"issue":"4","key":"10.1016\/j.addr.2026.115812_bb1025","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1002\/btpr.168","article-title":"Theoretical analysis of excipient concentrations during the final ultrafiltration\/diafiltration step of therapeutic antibody","volume":"25","author":"Miao","year":"2009","journal-title":"Biotechnology Progress"},{"issue":"9","key":"10.1016\/j.addr.2026.115812_bb1030","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1002\/bit.29038","article-title":"Integration of Single Pass Tangential Flow Filtration and High Performance Countercurrent Membrane Purification for Intensification of Monoclonal Antibody Processing","volume":"122","author":"Minervini","year":"2025","journal-title":"Biotechnology and Bioengineering"},{"key":"10.1016\/j.addr.2026.115812_bb1035","first-page":"22","article-title":"Lyophilization Presents Complex","volume":"33","author":"Mirasol","year":"2020","journal-title":"Challenges"},{"issue":"9","key":"10.1016\/j.addr.2026.115812_bb1040","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/nrd4363","article-title":"Overcoming the challenges in administering biopharmaceuticals: Formulation and delivery strategies","volume":"13","author":"Mitragotri","year":"2014","journal-title":"Nature Reviews Drug Discovery"},{"issue":"6","key":"10.1016\/j.addr.2026.115812_bb1045","doi-asserted-by":"crossref","DOI":"10.1002\/btpr.3481","article-title":"Buffer effects on protein sieving losses in ultrafiltration and their relationship to biophysical properties","volume":"40","author":"Mohammadzadehmarandi","year":"2024","journal-title":"Biotechnology Progress"},{"issue":"1","key":"10.1016\/j.addr.2026.115812_bb1050","doi-asserted-by":"crossref","first-page":"58","DOI":"10.37934\/cfdl.13.1.5871","article-title":"Mixing Performance of Anchor and Helical Stirrer Blades for Viscous Fluid Applications","volume":"13","author":"Mohd Yusof","year":"2021","journal-title":"CFD Letters"},{"issue":"12","key":"10.1016\/j.addr.2026.115812_bb1055","doi-asserted-by":"crossref","first-page":"5737","DOI":"10.1007\/s12206-018-1121-9","article-title":"Current engineering and clinical aspects of needle-free injectors: A review","volume":"32","author":"Mohizin","year":"2018","journal-title":"Journal of Mechanical Science and Technology"},{"issue":"2","key":"10.1016\/j.addr.2026.115812_bb1060","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/0095-8522(51)90036-0","article-title":"The viscosity of a concentrated suspension of spherical particles","volume":"6","author":"Mooney","year":"1951","journal-title":"Journal of Colloid Science"},{"issue":"9","key":"10.1016\/j.addr.2026.115812_bb1065","doi-asserted-by":"crossref","first-page":"4698","DOI":"10.1021\/acs.molpharmaceut.3c00440","article-title":"Biophysical Determinants for the Viscosity of Concentrated Monoclonal Antibody Solutions","volume":"20","author":"Mosca","year":"2023","journal-title":"Molecular Pharmaceutics"},{"issue":"2","key":"10.1016\/j.addr.2026.115812_bb1070","doi-asserted-by":"crossref","first-page":"141","DOI":"10.4155\/pbp.14.7","article-title":"A high throughput ultra performance size exclusion chromatography assay for the analysis of aggregates and fragments of monoclonal antibodies","volume":"2","author":"Mou","year":"2014","journal-title":"Pharmaceutical Bioprocessing"},{"issue":"9","key":"10.1016\/j.addr.2026.115812_bb1075","first-page":"2980","article-title":"Trehalose in cryopreservation. Applications, mechanisms and intracellular delivery opportunities. RSC","volume":"15","author":"Murray","year":"2024","journal-title":"Medicinal Chemistry"},{"issue":"10","key":"10.1016\/j.addr.2026.115812_bb1080","doi-asserted-by":"crossref","first-page":"4198","DOI":"10.1002\/jps.22676","article-title":"Characterization of subvisible particle formation during the filling pump operation of a monoclonal antibody solution","volume":"100","author":"Nayak","year":"2011","journal-title":"Journal of Pharmaceutical Sciences"},{"issue":"5","key":"10.1016\/j.addr.2026.115812_bb1085","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1016\/S0006-3495(98)77691-X","article-title":"Molecular Origins of Osmotic Second Virial Coefficients of Proteins","volume":"75","author":"Neal","year":"1998","journal-title":"Biophysical Journal"},{"issue":"10","key":"10.1016\/j.addr.2026.115812_bb1090","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/nrd3229","article-title":"Development trends for human monoclonal antibody therapeutics","volume":"9","author":"Nelson","year":"2010","journal-title":"Nature Reviews Drug Discovery"},{"issue":"7","key":"10.1016\/j.addr.2026.115812_bb1095","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1007\/s11095-010-0125-7","article-title":"Phase Separation of an IgG1 Antibody Solution under a Low Ionic Strength Condition","volume":"27","author":"Nishi","year":"2010","journal-title":"Pharmaceutical Research"},{"issue":"2","key":"10.1016\/j.addr.2026.115812_bb1100","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.xphs.2019.11.005","article-title":"Suck-Back Impact on Fluid Behavior at Filling Needle Tip","volume":"109","author":"Novaes Silva","year":"2020","journal-title":"Journal of Pharmaceutical Sciences"},{"issue":"8","key":"10.1016\/j.addr.2026.115812_bb1105","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1080\/19420862.2017.1368602","article-title":"Forced degradation of recombinant monoclonal antibodies: A practical guide","volume":"9","author":"Nowak","year":"2017","journal-title":"mAbs"},{"key":"10.1016\/j.addr.2026.115812_bb1110","series-title":"Optimizing Efficiency in High-Concentration Biopharmaceutical Production","author":"\u00d3lafsd\u00f3ttir","year":"2024"},{"issue":"1","key":"10.1016\/j.addr.2026.115812_bb1115","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1186\/s12889-022-14314-2","article-title":"Barriers and recommendations for a cervical cancer screening program among women in low-resource settings in Lagos Nigeria: A qualitative study","volume":"22","author":"Olubodun","year":"2022","journal-title":"BMC Public Health"},{"key":"10.1016\/j.addr.2026.115812_bb1120","series-title":"IoT Applications in Cold Chain Management for Pharmaceuticals: Ensuring Product Integrity and Safety. 2024 5th International Conference on Recent Trends in Computer Science and Technology (ICRTCST), 66\u201370","author":"Panigrahi","year":"2024"},{"issue":"4","key":"10.1016\/j.addr.2026.115812_bb1125","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.xphs.2022.11.017","article-title":"Investigating and Addressing Challenges Associated with Filling Protein Drug Products","volume":"112","author":"Pardeshi","year":"2023","journal-title":"Journal of Pharmaceutical Sciences"},{"issue":"3","key":"10.1016\/j.addr.2026.115812_bb1130","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1208\/s12249-021-01949-4","article-title":"Container Closure and Delivery Considerations for Intravitreal Drug Administration","volume":"22","author":"Parenky","year":"2021","journal-title":"AAPS PharmSciTech"},{"issue":"4","key":"10.1016\/j.addr.2026.115812_bb1135","doi-asserted-by":"crossref","first-page":"601","DOI":"10.3390\/polym13040601","article-title":"Comparison of Huggins Coefficients and Osmotic Second Virial Coefficients of Buffered Solutions of Monoclonal Antibodies","volume":"13","author":"Pathak","year":"2021","journal-title":"Polymers"},{"key":"10.1016\/j.addr.2026.115812_bb1140","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119523","article-title":"Protein aggregation and immunogenicity of biotherapeutics","volume":"585","author":"Pham","year":"2020","journal-title":"International Journal of Pharmaceutics"},{"issue":"11","key":"10.1016\/j.addr.2026.115812_bb1145","doi-asserted-by":"crossref","first-page":"3896","DOI":"10.1021\/acs.molpharmaceut.5b00336","article-title":"Solubility Challenges in High Concentration Monoclonal Antibody Formulations: Relationship with Amino Acid Sequence and Intermolecular Interactions","volume":"12","author":"Pindrus","year":"2015","journal-title":"Molecular Pharmaceutics"},{"issue":"8","key":"10.1016\/j.addr.2026.115812_bb1150","doi-asserted-by":"crossref","first-page":"5387","DOI":"10.1021\/acs.langmuir.4c04942","article-title":"Patchy Charge Distribution Affects the pH in Protein Solutions during Dialysis","volume":"41","author":"Pineda","year":"2025","journal-title":"Langmuir"},{"issue":"10","key":"10.1016\/j.addr.2026.115812_bb1155","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/S1470-2045(13)70383-8","article-title":"Preference for subcutaneous or intravenous administration of trastuzumab in patients with HER2-positive early breast cancer (PrefHer): An open-label randomised study","volume":"14","author":"Pivot","year":"2013","journal-title":"The Lancet Oncology"},{"issue":"8","key":"10.1016\/j.addr.2026.115812_bb1160","doi-asserted-by":"crossref","first-page":"780","DOI":"10.3390\/membranes12080780","article-title":"Effects of Viscosity on Submerged Membrane Microfiltration Systems","volume":"12","author":"Pradhan","year":"2022","journal-title":"Membranes"},{"key":"10.1016\/j.addr.2026.115812_bb1165","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2025.125451","article-title":"Additive effects of the new viscosity-reducing and stabilizing excipients for monoclonal antibody formulation","volume":"674","author":"Pra\u0161nikar","year":"2025","journal-title":"International Journal of Pharmaceutics"},{"issue":"19","key":"10.1016\/j.addr.2026.115812_bb1170","doi-asserted-by":"crossref","first-page":"6129","DOI":"10.1021\/acs.jcim.3c00947","article-title":"Viscosity Prediction of High-Concentration Antibody Solutions with Atomistic Simulations","volume":"63","author":"Prass","year":"2023","journal-title":"Journal of Chemical Information and Modeling"},{"issue":"9","key":"10.1016\/j.addr.2026.115812_bb1175","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1002\/jps.21617","article-title":"Characterization of the photodegradation of a human IgG1 monoclonal antibody formulated as a high-concentration liquid dosage form","volume":"98","author":"Qi","year":"2009","journal-title":"Journal of Pharmaceutical Sciences"},{"issue":"5","key":"10.1016\/j.addr.2026.115812_bb1180","doi-asserted-by":"crossref","first-page":"368","DOI":"10.3390\/membranes11050368","article-title":"Prediction of Permeate Flux in Ultrafiltration Processes: A Review of Modeling Approaches","volume":"11","author":"Quezada","year":"2021","journal-title":"Membranes"},{"issue":"51","key":"10.1016\/j.addr.2026.115812_bb1185","doi-asserted-by":"crossref","first-page":"35947","DOI":"10.1039\/D3RA06476J","article-title":"Stabilization challenges and aggregation in protein-based therapeutics in the pharmaceutical industry","volume":"13","author":"Rahban","year":"2023","journal-title":"RSC Advances"},{"issue":"2","key":"10.1016\/j.addr.2026.115812_bb1190","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1002\/btpr.2065","article-title":"From osmotic second virial coefficient (B22) to phase behavior of a monoclonal antibody","volume":"31","author":"Rakel","year":"2015","journal-title":"Biotechnology Progress"},{"issue":"12","key":"10.1016\/j.addr.2026.115812_bb1195","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1002\/bit.24577","article-title":"Recovery modeling of tangential flow systems","volume":"109","author":"Rao","year":"2012","journal-title":"Biotechnology and Bioengineering"},{"issue":"3","key":"10.1016\/j.addr.2026.115812_bb1200","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1021\/bp070462h","article-title":"Current Perspectives on Stability of Protein Drug Products during Formulation","volume":"24","author":"Rathore","year":"2008","journal-title":"Fill and Finish Operations. Biotechnology Progress"},{"issue":"5","key":"10.1016\/j.addr.2026.115812_bb1205","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1021\/acs.molpharmaceut.5b00937","article-title":"Pharmaceutical Perspective on Opalescence and Liquid\u2013Liquid Phase Separation in Protein Solutions","volume":"13","author":"Raut","year":"2016","journal-title":"Molecular Pharmaceutics"},{"issue":"4","key":"10.1016\/j.addr.2026.115812_bb1210","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1093\/abt\/tbad022","article-title":"Effects of arginine in therapeutic protein formulations: A decade review and perspectives","volume":"6","author":"Ren","year":"2023","journal-title":"Antibody Therapeutics"},{"key":"10.1016\/j.addr.2026.115812_bb1215","author":"de los Reyes"},{"key":"10.1016\/j.addr.2026.115812_bb1220","series-title":"Intermolecular interactions and rheological properties in monoclonal antibody solutions. The university of manchester","author":"Roche","year":"2020"},{"issue":"3","key":"10.1016\/j.addr.2026.115812_bb1225","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.xphs.2020.12.016","article-title":"Product-Specific Impact of Viscosity Modulating Formulation Excipients During Ultra-High Concentration Biotherapeutics Drug Product Development","volume":"110","author":"Rodrigues","year":"2021","journal-title":"Journal of Pharmaceutical Sciences"},{"issue":"8","key":"10.1016\/j.addr.2026.115812_bb1230","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1002\/bit.27801","article-title":"Adsorbed protein film on pump surfaces leads to particle formation during fill-finish manufacturing","volume":"118","author":"Roffi","year":"2021","journal-title":"Biotechnology and Bioengineering"},{"issue":"6","key":"10.1016\/j.addr.2026.115812_bb1235","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1208\/s12249-025-03189-2","article-title":"Exploring Protein Aggregation in Biological Products: From Mechanistic Understanding to Practical Solutions","volume":"26","author":"Rojekar","year":"2025","journal-title":"AAPS PharmSciTech"},{"issue":"9","key":"10.1016\/j.addr.2026.115812_bb1240","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1007\/s00216-019-02318-8","article-title":"Multi-attribute PAT for UF\/DF of Proteins\u2014Monitoring Concentration, particle sizes, and Buffer Exchange","volume":"412","author":"Rolinger","year":"2020","journal-title":"Analytical and Bioanalytical Chemistry"},{"issue":"4","key":"10.1016\/j.addr.2026.115812_bb1245","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0006-291X(77)90950-0","article-title":"Hard quasispherical model for the viscosity of hemoglobin solutions","volume":"76","author":"Ross","year":"1977","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"8","key":"10.1016\/j.addr.2026.115812_bb1250","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1039\/D3AN00076A","article-title":"Protein\u2013protein interactions in solutions of monoclonal antibodies probed by the dependence of the high-frequency viscosity on temperature and concentration","volume":"148","author":"Rott","year":"2023","journal-title":"The Analyst"},{"issue":"9","key":"10.1016\/j.addr.2026.115812_bb1255","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1016\/j.xphs.2021.05.012","article-title":"Polysorbate Degradation and Particle Formation in a High Concentration mAb: Formulation Strategies to Minimize Effect of Enzymatic Polysorbate Degradation","volume":"110","author":"Roy","year":"2021","journal-title":"Journal of Pharmaceutical Sciences"},{"issue":"7","key":"10.1016\/j.addr.2026.115812_bb1260","doi-asserted-by":"crossref","first-page":"459","DOI":"10.3111\/13696998.2014.914033","article-title":"Subcutaneous vs intravenous rituximab in patients with non-Hodgkin lymphoma: A time and motion study in the United Kingdom","volume":"17","author":"Rule","year":"2014","journal-title":"Journal of Medical Economics"},{"issue":"1","key":"10.1016\/j.addr.2026.115812_bb1265","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1021\/bp0001314","article-title":"Correlation between the Osmotic Second Virial Coefficient and the Solubility of Proteins","volume":"17","author":"Ruppert","year":"2001","journal-title":"Biotechnology Progress"},{"issue":"3","key":"10.1016\/j.addr.2026.115812_bb1270","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0011-9164(01)85005-0","article-title":"Concentration polarization in ultrafiltration and reverse osmosis: A critical review","volume":"141","author":"Sablani","year":"2001","journal-title":"Desalination"},{"issue":"1","key":"10.1016\/j.addr.2026.115812_bb1275","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3109\/10837450903511178","article-title":"Practical fundamentals of glass, rubber, and plastic sterile packaging systems","volume":"15","author":"Sacha","year":"2010","journal-title":"Pharmaceutical Development and Technology"},{"issue":"1","key":"10.1016\/j.addr.2026.115812_bb1280","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/10837450.2014.982825","article-title":"Pre-filled syringes: A review of the history, manufacturing and challenges","volume":"20","author":"Sacha","year":"2015","journal-title":"Pharmaceutical Development and Technology"},{"key":"10.1016\/j.addr.2026.115812_bb1285","article-title":"Impact of PFS and Filling Process Selection on Biologic Product Stability | Pharmaceutical Technology","author":"Saffell-Clemmer","year":"2017","journal-title":"Pharmaceutical Technology."},{"key":"10.1016\/j.addr.2026.115812_bb1290","series-title":"Computer Aided Pharmaceutics and Drug Delivery: An Application Guide for Students and Researchers of Pharmaceutical Sciences","first-page":"381","article-title":"Robotic Automation of Pharmaceutical and Life Science Industries","author":"Saharan","year":"2022"},{"issue":"2","key":"10.1016\/j.addr.2026.115812_bb1295","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s12247-019-09414-3","article-title":"Challenges and Considerations in Development and Manufacturing of High Concentration Biologics Drug Products","volume":"15","author":"Sahin","year":"2020","journal-title":"Journal of Pharmaceutical Innovation"},{"issue":"2","key":"10.1016\/j.addr.2026.115812_bb1300","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s11095-011-0563-x","article-title":"Behavior of Monoclonal Antibodies: Relation Between the Second Virial Coefficient (B2) at Low Concentrations and Aggregation Propensity and Viscosity at High Concentrations","volume":"29","author":"Saito","year":"2012","journal-title":"Pharmaceutical Research"},{"issue":"5","key":"10.1016\/j.addr.2026.115812_bb1305","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/jphp.12603","article-title":"Influence of particle shedding from silicone tubing on antibody stability","volume":"70","author":"Saller","year":"2018","journal-title":"Journal of Pharmacy and Pharmacology"},{"issue":"12","key":"10.1016\/j.addr.2026.115812_bb1310","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.1002\/jps.20970","article-title":"Ultrasonic rheology of a monoclonal antibody (IgG2) solution: Implications for physical stability of proteins in high concentration formulations","volume":"96","author":"Saluja","year":"2007","journal-title":"Journal of Pharmaceutical Sciences"},{"issue":"4","key":"10.1016\/j.addr.2026.115812_bb1315","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1021\/acs.molpharmaceut.3c01157","article-title":"Impact of Excipient Extraction and Buffer Exchange on Recombinant Monoclonal Antibody Stability","volume":"21","author":"Sarin","year":"2024","journal-title":"Molecular Pharmaceutics"},{"key":"10.1016\/j.addr.2026.115812_bb1320","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1151888","article-title":"Understanding preclinical and clinical immunogenicity risks in novel biotherapeutics development","volume":"14","author":"Sauna","year":"2023","journal-title":"Frontiers in Immunology"},{"issue":"1","key":"10.1016\/j.addr.2026.115812_bb1325","doi-asserted-by":"crossref","first-page":"2169440","DOI":"10.1080\/19420862.2023.2169440","article-title":"Predictive modeling of concentration-dependent viscosity behavior of monoclonal antibody solutions using artificial neural networks","volume":"15","author":"Schmitt","year":"2023","journal-title":"mAbs"},{"key":"10.1016\/j.addr.2026.115812_bb1330","series-title":"Introduction to Tangential Flow Filtration for Laboratory and Process Development Applications","author":"Schwartz","year":"2008"},{"key":"10.1016\/j.addr.2026.115812_bb1335","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.desal.2014.10.031","article-title":"Forward osmosis: Where are we now?","volume":"356","author":"Shaffer","year":"2015","journal-title":"Desalination"},{"issue":"8","key":"10.1016\/j.addr.2026.115812_bb1340","doi-asserted-by":"crossref","first-page":"5021","DOI":"10.1021\/acs.molpharmaceut.5c00673","article-title":"Predicting the Effects of Charge Mutations on the Second Osmotic Virial Coefficient for Therapeutic Antibodies via Coarse-Grained Molecular Simulations and Deep Learning Methods","volume":"22","author":"Shahfar","year":"2025","journal-title":"Molecular Pharmaceutics"},{"issue":"1","key":"10.1016\/j.addr.2026.115812_bb1345","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/bit.20009","article-title":"Retention of small charged impurities during ultrafiltration","volume":"87","author":"Shao","year":"2004","journal-title":"Biotechnology and Bioengineering"},{"key":"10.1016\/j.addr.2026.115812_bb1350","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2024.465651","article-title":"A review of polysorbate quantification and its degradation analysis by liquid chromatography coupled with charged aerosol detection","volume":"1742","author":"Shi","year":"2025","journal-title":"Journal of Chromatography A"},{"issue":"2","key":"10.1016\/j.addr.2026.115812_bb1355","doi-asserted-by":"crossref","first-page":"153","DOI":"10.5731\/pdajpst.2014.00973","article-title":"Filling of High-Concentration Monoclonal Antibody Formulations into Pre-Filled Syringes: Filling Parameter Investigation and Optimization","volume":"68","author":"Shieu","year":"2014","journal-title":"PDA Journal of Pharmaceutical Science and Technology"},{"issue":"6","key":"10.1016\/j.addr.2026.115812_bb1360","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1002\/jps.20079","article-title":"Challenges in the development of high protein concentration formulations","volume":"93","author":"Shire","year":"2004","journal-title":"Journal of Pharmaceutical Sciences"},{"key":"10.1016\/j.addr.2026.115812_bb1365","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2025.107064","article-title":"Assessing impact of hinge flexibility on predicted second osmotic virial coefficients","volume":"209","author":"Shoemaker","year":"2025","journal-title":"European Journal of Pharmaceutical Sciences"},{"issue":"1","key":"10.1016\/j.addr.2026.115812_bb1370","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/btm2.10061","article-title":"Evolving trends in mAb production processes","volume":"2","author":"Shukla","year":"2017","journal-title":"Bioengineering & Translational Medicine"},{"key":"10.1016\/j.addr.2026.115812_bb1375","first-page":"30","volume":"42","author":"Siew","year":"2018","journal-title":"Delivering High-Concentration Protein Formulations."},{"issue":"8","key":"10.1016\/j.addr.2026.115812_bb1380","doi-asserted-by":"crossref","first-page":"3302","DOI":"10.1002\/jps.22097","article-title":"An Industry Perspective on the Monitoring of Subvisible Particles as a Quality Attribute for Protein Therapeutics","volume":"99","author":"Singh","year":"2010","journal-title":"Journal of Pharmaceutical Sciences"},{"key":"10.1016\/j.addr.2026.115812_bb1385","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ejpb.2021.08.010","article-title":"Rapid aggregation of therapeutic monoclonal antibodies by bubbling induced air\/liquid interfacial and agitation stress at different conditions","volume":"168","author":"Sreenivasan","year":"2021","journal-title":"European Journal of Pharmaceutics and Biopharmaceutics"},{"key":"10.1016\/j.addr.2026.115812_bb1390","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124735","article-title":"Aggregation of therapeutic monoclonal antibodies due to thermal and air\/liquid interfacial agitation stress: Occurrence, stability assessment strategies, aggregation mechanism, influencing factors, and ways to enhance stability","volume":"666","author":"Sreenivasan","year":"2024","journal-title":"International Journal of Pharmaceutics"},{"issue":"6","key":"10.1016\/j.addr.2026.115812_bb1395","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1080\/03091902.2025.2508893","article-title":"A detailed review of the recent development of needle-free drug delivery devices","volume":"49","author":"Srivastava","year":"2025","journal-title":"Journal of Medical Engineering & Technology"},{"issue":"10","key":"10.1016\/j.addr.2026.115812_bb1400","doi-asserted-by":"crossref","first-page":"2848","DOI":"10.1016\/j.xphs.2022.05.011","article-title":"Viscosity Reduction and Stability Enhancement of Monoclonal Antibody Formulations Using Derivatives of Amino Acids","volume":"111","author":"Srivastava","year":"2022","journal-title":"Journal of Pharmaceutical Sciences"},{"issue":"7","key":"10.1016\/j.addr.2026.115812_bb1405","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.1021\/acs.molpharmaceut.1c00280","article-title":"Ultradilute Measurements of Self-Association for the Identification of Antibodies with Favorable High-Concentration Solution Properties","volume":"18","author":"Starr","year":"2021","journal-title":"Molecular Pharmaceutics"},{"key":"10.1016\/j.addr.2026.115812_bb1410","first-page":"344","article-title":"A field based evaluation of adverse events following MenAfriVac\u00aevaccine delivered in a controlled temperature chain (CTC) approach in Benin","volume":"18","author":"Steffen","year":"2014","journal-title":"The Pan African Medical Journal"},{"issue":"9","key":"10.1016\/j.addr.2026.115812_bb1415","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1002\/jps.20145","article-title":"Protein-solute interactions affect the outcome of ultrafiltration\/diafiltration operations","volume":"93","author":"Stoner","year":"2004","journal-title":"Journal of Pharmaceutical Sciences"},{"key":"10.1016\/j.addr.2026.115812_bb1420","doi-asserted-by":"crossref","DOI":"10.56530\/lcgc.int.it7675n7","article-title":"Analysis of Therapeutic Monoclonal Antibodies Using a Platform Size Exclusion-HPLC Method","author":"Sutton","year":"2024","journal-title":"LCGC International."},{"key":"10.1016\/j.addr.2026.115812_bb1425","doi-asserted-by":"crossref","DOI":"10.1016\/j.memsci.2025.123839","article-title":"The application of forward osmosis for producing highly concentrated biotherapeutics","volume":"721","author":"Tangry","year":"2025","journal-title":"Journal of Membrane Science"},{"key":"10.1016\/j.addr.2026.115812_bb1430","doi-asserted-by":"crossref","DOI":"10.1016\/j.jwpe.2022.103294","article-title":"A review of membrane fouling by proteins in ultrafiltration and microfiltration","volume":"50","author":"Tanudjaja","year":"2022","journal-title":"Journal of Water Process Engineering"},{"issue":"6","key":"10.1016\/j.addr.2026.115812_bb1435","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.3390\/pharmaceutics15061581","article-title":"Robotics and Aseptic Processing in View of Regulatory Requirements","volume":"15","author":"Tanzini","year":"2023","journal-title":"Pharmaceutics"},{"issue":"6","key":"10.1016\/j.addr.2026.115812_bb1440","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1002\/bit.23067","article-title":"Predicting diafiltration solution compositions for final ultrafiltration\/diafiltration steps of monoclonal antibodies","volume":"108","author":"Teeters","year":"2011","journal-title":"Biotechnology and Bioengineering"},{"issue":"2","key":"10.1016\/j.addr.2026.115812_bb1445","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/jps.24242","article-title":"Characterization of the Physical Stability of a Lyophilized IgG1 mAb After Accelerated Shipping-like Stress","volume":"104","author":"Telikepalli","year":"2015","journal-title":"Journal of Pharmaceutical Sciences"},{"issue":"11","key":"10.1016\/j.addr.2026.115812_bb1450","doi-asserted-by":"crossref","first-page":"3340","DOI":"10.1016\/j.xphs.2020.08.018","article-title":"Can Cross-Linked Siliconized PFS Come to the Rescue of the Biologics Drug Product?","volume":"109","author":"Thakare","year":"2020","journal-title":"Journal of Pharmaceutical Sciences"},{"key":"10.1016\/j.addr.2026.115812_bb1455","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120456","article-title":"Near Infrared Spectroscopy as a PAT tool for monitoring and control of protein and excipient concentration in ultrafiltration of highly concentrated antibody formulations","volume":"600","author":"Thakur","year":"2021","journal-title":"International Journal of Pharmaceutics"},{"key":"10.1016\/j.addr.2026.115812_bb1460","doi-asserted-by":"crossref","DOI":"10.1016\/j.memsci.2020.118492","article-title":"Implementing PAT for single-pass tangential flow ultrafiltration for continuous manufacturing of monoclonal antibodies","volume":"613","author":"Thakur","year":"2020","journal-title":"Journal of Membrane Science"},{"issue":"9","key":"10.1016\/j.addr.2026.115812_bb1465","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1002\/jps.21719","article-title":"Silicone Oil- and Agitation-Induced Aggregation of a Monoclonal Antibody in Aqueous Solution","volume":"98","author":"Thirumangalathu","year":"2009","journal-title":"Journal of Pharmaceutical Sciences"},{"key":"10.1016\/j.addr.2026.115812_bb1470","series-title":"Sterile Product Development: Formulation, Process, Quality and Regulatory Considerations","first-page":"331","article-title":"Pen and Autoinjector Drug Delivery Devices","author":"Thompson","year":"2013"},{"issue":"2","key":"10.1016\/j.addr.2026.115812_bb1475","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1080\/19420862.2015.1128606","article-title":"Molecular basis of high viscosity in concentrated antibody solutions: Strategies for high concentration drug product development","volume":"8","author":"Tomar","year":"2016","journal-title":"mAbs"},{"issue":"3","key":"10.1016\/j.addr.2026.115812_bb1480","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1080\/19420862.2017.1285479","article-title":"In-silico prediction of concentration-dependent viscosity curves for monoclonal antibody solutions","volume":"9","author":"Tomar","year":"2017","journal-title":"mAbs"},{"issue":"3","key":"10.1016\/j.addr.2026.115812_bb1485","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1177\/2042098611406318","article-title":"Immunogenicity and other problems associated with the use of biopharmaceuticals","volume":"2","author":"Tovey","year":"2011","journal-title":"Therapeutic Advances in Drug Safety"},{"issue":"6","key":"10.1016\/j.addr.2026.115812_bb1490","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1007\/s12551-022-01032-7","article-title":"Protein\u2013protein interaction prediction methods: From docking-based to AI-based approaches","volume":"14","author":"Tsuchiya","year":"2022","journal-title":"Biophysical Reviews"},{"issue":"8","key":"10.1016\/j.addr.2026.115812_bb1495","doi-asserted-by":"crossref","DOI":"10.1016\/j.xphs.2025.103848","article-title":"Effect of silicone oil on the structure, stability, and aggregation of a therapeutic antibody","volume":"114","author":"Upadhyay","year":"2025","journal-title":"Journal of Pharmaceutical Sciences"},{"issue":"11","key":"10.1016\/j.addr.2026.115812_bb1500","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1007\/s12325-019-01101-6","article-title":"Subcutaneous Injection of Drugs: Literature Review of Factors Influencing Pain Sensation at the Injection Site","volume":"36","author":"Usach","year":"2019","journal-title":"Advances in Therapy"},{"issue":"8","key":"10.1016\/j.addr.2026.115812_bb1505","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/j.jmb.2017.03.014","article-title":"Prediction and Reduction of the Aggregation of Monoclonal Antibodies","volume":"429","author":"van der Kant","year":"2017","journal-title":"Journal of Molecular Biology"},{"key":"10.1016\/j.addr.2026.115812_bb1510","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jconrel.2018.08.001","article-title":"Subcutaneous delivery of monoclonal antibodies: How do we get there?","volume":"286","author":"Viola","year":"2018","journal-title":"Journal of Controlled Release"},{"issue":"3","key":"10.1016\/j.addr.2026.115812_bb1515","first-page":"253","volume":"3","author":"Vlasak","year":"2011","journal-title":"Fragmentation of monoclonal antibodies. mAbs"},{"issue":"20","key":"10.1016\/j.addr.2026.115812_bb1520","doi-asserted-by":"crossref","first-page":"9843","DOI":"10.1073\/pnas.1817564116","article-title":"Dynamic cluster formation determines viscosity and diffusion in dense protein solutions","volume":"116","author":"von B\u00fclow","year":"2019","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"11","key":"10.1016\/j.addr.2026.115812_bb1525","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1016\/j.ces.2011.03.001","article-title":"Integrated forward osmosis\u2013membrane distillation (FO\u2013MD) hybrid system for the concentration of protein solutions","volume":"66","author":"Wang","year":"2011","journal-title":"Chemical Engineering Science"},{"issue":"12","key":"10.1016\/j.addr.2026.115812_bb1530","doi-asserted-by":"crossref","first-page":"4478","DOI":"10.1021\/acs.molpharmaceut.5b00643","article-title":"Viscosity-Lowering Effect of Amino Acids and Salts on Highly Concentrated Solutions of Two IgG1 Monoclonal Antibodies","volume":"12","author":"Wang","year":"2015","journal-title":"Molecular Pharmaceutics"},{"issue":"10","key":"10.1016\/j.addr.2026.115812_bb1535","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1080\/05704928.2017.1345758","article-title":"A review on the methods for correcting the fluorescence inner-filter effect of fluorescence spectrum","volume":"52","author":"Wang","year":"2017","journal-title":"Applied Spectroscopy Reviews"},{"issue":"3","key":"10.1016\/j.addr.2026.115812_bb1540","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1208\/s12248-013-9485-3","article-title":"Non-Arrhenius Protein Aggregation","volume":"15","author":"Wang","year":"2013","journal-title":"The AAPS Journal"},{"issue":"7","key":"10.1016\/j.addr.2026.115812_bb1545","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1021\/acs.jpcb.7b10728","article-title":"Cluster Size and Quinary Structure Determine the Rheological Effects of Antibody Self-Association at High Concentrations","volume":"122","author":"Wang","year":"2018","journal-title":"The Journal of Physical Chemistry B"},{"issue":"1","key":"10.1016\/j.addr.2026.115812_bb1550","doi-asserted-by":"crossref","first-page":"22150","DOI":"10.1038\/s41598-021-00899-y","article-title":"Calculation of the Gibbs\u2013Donnan factors for multi-ion solutions with non-permeating charge on both sides of a permselective membrane","volume":"11","author":"Waniewski","year":"2021","journal-title":"Scientific Reports"},{"key":"10.1016\/j.addr.2026.115812_bb1555","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.ijpharm.2018.11.012","article-title":"Injectability as a function of viscosity and dosing materials for subcutaneous administration","volume":"554","author":"Watt","year":"2019","journal-title":"International Journal of Pharmaceutics"},{"key":"10.1016\/j.addr.2026.115812_bb1560","series-title":"Parenteral Medications","article-title":"Plastic Packaging for Parenteral Drug Delivery","author":"Waxman","year":"2019"},{"issue":"5","key":"10.1016\/j.addr.2026.115812_bb1565","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s10337-021-04015-0","article-title":"Appearance and Formation Analysis of Multimers in High Concentration Antibodies","volume":"84","author":"Weng","year":"2021","journal-title":"Chromatographia"},{"issue":"3","key":"10.1016\/j.addr.2026.115812_bb1570","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.xphs.2018.10.049","article-title":"Silicone Oil-Free Polymer Syringes for the Storage of Therapeutic Proteins","volume":"108","author":"Werner","year":"2019","journal-title":"Journal of Pharmaceutical Sciences"},{"issue":"6","key":"10.1016\/j.addr.2026.115812_bb1575","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1002\/bit.27741","article-title":"Process analytical technology for on-line monitoring of quality attributes during single-use ultrafiltration\/diafiltration","volume":"118","author":"West","year":"2021","journal-title":"Biotechnology and Bioengineering"},{"issue":"11","key":"10.1016\/j.addr.2026.115812_bb1580","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.1016\/j.xphs.2022.08.001","article-title":"Developability Assessments of Monoclonal Antibody Candidates to Minimize Aggregation During Large-Scale Ultrafiltration and Diafiltration (UF-DF) Processing","volume":"111","author":"Whitaker","year":"2022","journal-title":"Journal of Pharmaceutical Sciences"},{"issue":"11","key":"10.1016\/j.addr.2026.115812_bb1585","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.1016\/j.xphs.2017.06.017","article-title":"A Formulation Development Approach to Identify and Select Stable Ultra\u2013High-Concentration Monoclonal Antibody Formulations With Reduced Viscosities","volume":"106","author":"Whitaker","year":"2017","journal-title":"Journal of Pharmaceutical Sciences"},{"key":"10.1016\/j.addr.2026.115812_bb1590","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ab.2015.08.020","article-title":"The osmotic second virial coefficient for protein self-interaction: Use and misuse to describe thermodynamic nonideality","volume":"490","author":"Wills","year":"2015","journal-title":"Analytical Biochemistry"},{"issue":"1","key":"10.1016\/j.addr.2026.115812_bb1595","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.xphs.2018.07.007","article-title":"How Well Do Low- and High-Concentration Protein Interactions Predict Solution Viscosities of Monoclonal Antibodies?","volume":"108","author":"Woldeyes","year":"2019","journal-title":"Journal of Pharmaceutical Sciences"},{"issue":"12","key":"10.1016\/j.addr.2026.115812_bb1600","doi-asserted-by":"crossref","first-page":"4473","DOI":"10.1021\/acs.molpharmaceut.0c00552","article-title":"Temperature Dependence of Protein Solution Viscosity and Protein\u2013Protein Interactions: Insights into the Origins of High-Viscosity Protein Solutions","volume":"17","author":"Woldeyes","year":"2020","journal-title":"Molecular Pharmaceutics"},{"key":"10.1016\/j.addr.2026.115812_bb1605","series-title":"Formulation Effects on Opalescence of a High-Concentration MAb","author":"Woods","year":"2010"},{"issue":"47","key":"10.1016\/j.addr.2026.115812_bb1610","doi-asserted-by":"crossref","first-page":"11676","DOI":"10.1021\/acs.jpcb.4c06877","article-title":"Diffusion and Viscosity in Mixed Protein Solutions","volume":"128","author":"Wozniak","year":"2024","journal-title":"The Journal of Physical Chemistry. B"},{"issue":"4","key":"10.1016\/j.addr.2026.115812_bb1615","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1093\/abt\/tbae028","article-title":"Leveraging high-throughput analytics and automation to rapidly develop high-concentration mAb formulations: Integrated excipient compatibility and viscosity screening","volume":"7","author":"Xin","year":"2024","journal-title":"Antibody Therapeutics"},{"issue":"1","key":"10.1016\/j.addr.2026.115812_bb1620","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s11095-024-03801-3","article-title":"Rapid Development of High Concentration Protein Formulation Driven by High-Throughput Technologies","volume":"42","author":"Xin","year":"2025","journal-title":"Pharmaceutical Research"},{"issue":"10","key":"10.1016\/j.addr.2026.115812_bb1625","doi-asserted-by":"crossref","first-page":"4319","DOI":"10.1021\/acs.molpharmaceut.9b00687","article-title":"Studying Excipient Modulated Physical Stability and Viscosity of Monoclonal Antibody Formulations Using Small-Angle Scattering","volume":"16","author":"Xu","year":"2019","journal-title":"Molecular Pharmaceutics"},{"issue":"4","key":"10.1016\/j.addr.2026.115812_bb1630","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1021\/mp200566k","article-title":"The Influence of Charge Distribution on Self-Association and Viscosity Behavior of Monoclonal Antibody Solutions","volume":"9","author":"Yadav","year":"2012","journal-title":"Molecular Pharmaceutics"},{"issue":"2","key":"10.1016\/j.addr.2026.115812_bb1635","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s12551-013-0109-z","article-title":"Assessment and significance of protein\u2013protein interactions during development of protein biopharmaceuticals","volume":"5","author":"Yadav","year":"2013","journal-title":"Biophysical Reviews"},{"issue":"3","key":"10.1016\/j.addr.2026.115812_bb1640","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1002\/jps.21898","article-title":"Specific interactions in high concentration antibody solutions resulting in high viscosity","volume":"99","author":"Yadav","year":"2010","journal-title":"Journal of Pharmaceutical Sciences"},{"issue":"12","key":"10.1016\/j.addr.2026.115812_bb1645","doi-asserted-by":"crossref","first-page":"4812","DOI":"10.1002\/jps.22190","article-title":"Factors Affecting the Viscosity in High Concentration Solutions of Different Monoclonal Antibodies","volume":"99","author":"Yadav","year":"2010","journal-title":"Journal of Pharmaceutical Sciences"},{"issue":"3","key":"10.1016\/j.addr.2026.115812_bb1650","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1002\/jps.22831","article-title":"Viscosity Behavior of High-Concentration Monoclonal Antibody Solutions: Correlation with Interaction Parameter and Electroviscous Effects","volume":"101","author":"Yadav","year":"2012","journal-title":"Journal of Pharmaceutical Sciences"},{"issue":"4","key":"10.1016\/j.addr.2026.115812_bb1655","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1021\/acs.analchem.5b02800","article-title":"Isomerization and Oxidation in the Complementarity-Determining Regions of a Monoclonal Antibody: A Study of the Modification\u2013Structure\u2013Function Correlations by Hydrogen\u2013Deuterium Exchange Mass Spectrometry","volume":"88","author":"Yan","year":"2016","journal-title":"Analytical Chemistry"},{"issue":"9","key":"10.1016\/j.addr.2026.115812_bb1660","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1002\/bit.26329","article-title":"Multi-criteria manufacturability indices for ranking high-concentration monoclonal antibody formulations","volume":"114","author":"Yang","year":"2017","journal-title":"Biotechnology and Bioengineering"},{"issue":"8","key":"10.1016\/j.addr.2026.115812_bb1665","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1016\/j.bpj.2014.02.036","article-title":"Observation of Small Cluster Formation in Concentrated Monoclonal Antibody Solutions and Its Implications to Solution Viscosity","volume":"106","author":"Yearley","year":"2014","journal-title":"Biophysical Journal"},{"issue":"4","key":"10.1016\/j.addr.2026.115812_bb1670","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1080\/17425247.2021.1853699","article-title":"Development of syringes and vials for delivery of biologics: Current challenges and innovative solutions","volume":"18","author":"Yoneda","year":"2021","journal-title":"Expert Opinion on Drug Delivery"},{"issue":"2","key":"10.1016\/j.addr.2026.115812_bb1675","doi-asserted-by":"crossref","DOI":"10.1002\/btpr.3106","article-title":"A mechanistic model to account for the Donnan and volume exclusion effects in ultrafiltration\/diafiltration process of protein formulations","volume":"37","author":"Yu","year":"2021","journal-title":"Biotechnology Progress"},{"issue":"9","key":"10.1016\/j.addr.2026.115812_bb1680","doi-asserted-by":"crossref","first-page":"4553","DOI":"10.1021\/acs.molpharmaceut.4c00460","article-title":"Flow Activation Energy of High-Concentration Monoclonal Antibody Solutions and Protein\u2013Protein Interactions Influenced by NaCl and Sucrose","volume":"21","author":"Yuan","year":"2024","journal-title":"Molecular Pharmaceutics"},{"issue":"8","key":"10.1016\/j.addr.2026.115812_bb1685","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1002\/jps.23647","article-title":"High Shear Rheology and Anisotropy in Concentrated Solutions of Monoclonal Antibodies","volume":"102","author":"Zarraga","year":"2013","journal-title":"Journal of Pharmaceutical Sciences"},{"issue":"1","key":"10.1016\/j.addr.2026.115812_bb1690","doi-asserted-by":"crossref","first-page":"2211185","DOI":"10.1080\/19420862.2023.2211185","article-title":"High concentration formulation developability approaches and considerations","volume":"15","author":"Zarzar","year":"2023","journal-title":"mAbs"},{"key":"10.1016\/j.addr.2026.115812_bb1695","doi-asserted-by":"crossref","DOI":"10.1016\/j.chroma.2024.464777","article-title":"High throughput multidimensional liquid chromatography approach for online protein removal and characterization of polysorbates and poloxamer in monoclonal antibody formulations","volume":"1720","author":"Zegota","year":"2024","journal-title":"Journal of Chromatography A"},{"issue":"1","key":"10.1016\/j.addr.2026.115812_bb1700","doi-asserted-by":"crossref","first-page":"Article 1","DOI":"10.3390\/membranes13010077","article-title":"Reduction of Ultrafiltration Membrane Fouling by the Pretreatment Removal of Emerging Pollutants: A Review","volume":"13","author":"Zhang","year":"2023","journal-title":"Membranes"},{"key":"10.1016\/j.addr.2026.115812_bb1705","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.coche.2017.04.001","article-title":"Recent progresses of understanding the viscosity of concentrated protein solutions","volume":"16","author":"Zhang","year":"2017","journal-title":"Current Opinion in Chemical Engineering"},{"key":"10.1016\/j.addr.2026.115812_bb1710","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.jcis.2020.06.105","article-title":"Control of viscosity in biopharmaceutical protein formulations","volume":"580","author":"Zidar","year":"2020","journal-title":"Journal of Colloid and Interface Science"},{"issue":"9","key":"10.1016\/j.addr.2026.115812_bb1715","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1007\/s11095-017-2191-6","article-title":"High Throughput Prediction Approach for Monoclonal Antibody Aggregation at High Concentration","volume":"34","author":"Zidar","year":"2017","journal-title":"Pharmaceutical Research"},{"issue":"2","key":"10.1016\/j.addr.2026.115812_bb1720","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/bit.22308","article-title":"Membrane technology for purification of therapeutic proteins","volume":"103","author":"Zydney","year":"2009","journal-title":"Biotechnology and Bioengineering"},{"key":"10.1016\/j.addr.2026.115812_bib1721","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ijbiomac.2021.02.214","article-title":"Raman spectroscopy for in situ, real time monitoring of protein aggregation in lyophilized biotherapeutic products","volume":"179","author":"Nitika","year":"2021","journal-title":"International journal of biological macromolecules"}],"container-title":["Advanced Drug Delivery Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X26000463?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X26000463?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T08:33:29Z","timestamp":1779006809000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169409X26000463"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":345,"alternative-id":["S0169409X26000463"],"URL":"https:\/\/doi.org\/10.1016\/j.addr.2026.115812","relation":{},"ISSN":["0169-409X"],"issn-type":[{"value":"0169-409X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Challenges and developments in the manufacturing of high-concentration biotherapeutic monoclonal antibodies","name":"articletitle","label":"Article Title"},{"value":"Advanced Drug Delivery Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.addr.2026.115812","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"115812"}}